UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-K

~~(X)~~☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (FEE REQUIRED)

~~EXCHANGE~~For the ~~ACT~~fiscal OFyear ~~1934~~ended ~~(FEE~~December ~~REQUIRED)~~31, 2015

~~For~~☐ ~~the~~TRANSITION REPORT ~~fiscal~~PURSUANT ~~year~~TO ~~ended~~SECTION ~~December~~13 ~~31,~~or ~~2014~~15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED)

( ) TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934 (NO FEE REQUIRED)

For the transition period from ___________ to ___________

Commission File Number: 000-52890

UPLIFT NUTRITION, INC.

(Exact name of small business issuer as specified in its charter)

Common Capital Voting Stock, $0.001 par value per share

(Title of Class)

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ~~[ ]~~☐ No ~~[X]~~ ☒

as specified in its charter)

Nevada		20-4669109
(State or other jurisdiction of incorporation or organization		(I.R.S. Employer Identification No.)

575 Riverside Ave, Suite 102 Westport CT		06880
(Address of principal executive offices)		(Zip Code)

Nevada		20-4669109
(State or other jurisdiction of incorporation or organization		(I.R.S. Employer Identification No.)
2681 East Parleys Way, Suite 204 Salt Lake City, Utah		84109
(Address of principal executive offices)		(Zip Code)

203-513-9822

801-322-3401

(Registrant's telephone number, including area code)

Securities registered under Section 12(b) of the Act:

Title of each class		Name of each exchange on which registered
N/A		N/A

Securities registered under Section 12(g) of the Act:

~~Indicate~~Common Capital byVoting ~~check~~Stock, ~~mark whether the issuer is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act~~$0. ~~Yes~~001 ~~[ ]~~par Novalue ~~[X]~~per share

~~Indicate by check mark whether the issuer~~ (~~1) filed all reports required to be filed by Section 13 or 15(d)~~ Title of ~~the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports~~Class)~~, and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]~~

Indicate by check mark whether the ~~registrant~~issuer ~~has~~is ~~submitted~~not ~~electronically and posted on its corporate website, if any, every Interactive Data File~~ required to befile ~~submitted~~reports ~~and posted~~ pursuant to ~~Rule~~Section ~~405~~13 ofor ~~Regulation S-T~~ 15(~~§232.405~~d) of ~~this chapter) during~~ the ~~preceding~~Exchange ~~12 months (or for such shorter period that the registrant was required to submit and post such files)~~Act. Yes ☐ ~~[X]~~ No ~~[ ]~~☒

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files) Yes ☒ No ☐

Indicate by check mark if disclosure of delinquent filers in response to Item 405 of Regulation S-B contained in this form, and no disclosure will be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.

~~[X]~~☒ The issuer is not aware of any delinquent filers.

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company:

Large accelerated filer [☐ ] Accelerated filed [☐ ] Non-accelerated filer [☐ ] Smaller reporting company ~~[X]~~☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ~~[ ]~~☒ No ~~[X]~~☐

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. (See definition of affiliate in Rule 12b-2 of the Exchange Act.)

As of June 30, ~~2014~~2015, we had a total of 1346,892,597 common capital shares issued and outstanding of which 1044,~~843~~476,~~150~~140 are either "restricted” or otherwise owned and held by officers, directors, insiders and affiliates. This figure of 1044,~~843~~476,~~150~~ 140 “restricted” or affiliate shares includes a total of 1042,~~401~~476,~~550~~150 shares ~~owned~~being ~~and~~ held by Sharon Will, our ~~majority~~former ~~stockholder~~President and director, pursuant to irrevocable proxies. The total figure of 1044,~~843~~476,~~150~~140 insider-held shares represents 78approximately 95% of our total number of issued and outstanding shares. See Item 12 of Part III below. The aggregate market value of the voting stock held by non-affiliates, an amount consisting of a total of 32,~~049~~416,~~447~~457 shares or approximately 225% of our total number of issued and outstanding shares, was considered by us to have a value of approximately $~~152~~96,~~472~~658. This valuation is based on the ~~year~~ end bid price of our stock as of June 30, 2015, which was approximately $0.0504 per share. ~~See Item 5 below.~~ Our stock is quoted on the OTC Markets’ OTCQB under the symbol UPNT.

APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PAST FIVE YEARS:

Not applicable

(APPLICABLE ONLY TO CORPORATE REGISTRANTS)

State the number of shares outstanding of each of the issuer’s classes of common equity, as of ~~April~~January 1319, ~~2014~~2017: 13 64,~~892~~392,597 common shares; we have 10 million preferred shares authorized under our Articles, as amended, but none have been issued as of the date of this report.

We have 10 million preferred shares authorized under our Articles, as amended, but none has been issued as of the date of this report.

DOCUMENTS INCORPORATED BY REFERENCE

See Item 15 of Part IV below.

UPLIFT NUTRITION, INC.

INDEX

Part I

Item 1.	Business	1
Item 1A.	Risk Factors	4
Item 1B.	Unresolved Staff Comments	4
Item 2.	Properties	4
Item 3.	Legal Proceedings	4
Item 4.	Mine Safety Disclosure	4

Part II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	5
Item 6.	Selected Financial Data	10
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	13
Item 8.	Financial Statements and Supplementary Data	13
Item 9.	Changes In and Disagreements with Accountants on Accounting and Financial Disclosure	14
Item 9A.	Controls and Procedures	14
Item 9B.	Other Information	14

Part III

Item 10.	Directors, Executive Officers and Corporate Governance	15
Item 11.	Executive Compensation	18
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	20
Item 13.	Certain Relationships and Related Transactions, and Director Independence	21
Item 14.	Principal Accounting Fees and Services	26

Part IV

Item 15.	Exhibits, Financial Statement Schedules	27

Signatures		28

NOTICE AND DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS

Certain matters discussed herein may be forward-looking statements that involve a variety of risks and uncertainties. Because we are a Smaller Reporting Company, however, the modified Form 10-K does not require us to list risk factors in this annual report. Reference is made to Item 1A below titled “Risk Factors.” In light of the risks involved with or facing us, actual results may differ materially or considerably from those projected, implied or suggested. As a result, any forward-looking statements expressed herein are deemed to represent our best judgment as of the date of this filing. We do NOT express any intent or obligation to update any forward-looking statement because we are unable to give any assurances regarding the likelihood that, or extent to which, any event discussed in any such forward-looking statement contained herein may or may not occur, or that any effect from or outcome of any such forward-looking event may or may not bear materially upon our future business, prospects, plans, financial condition or our plan of operation.

TABLE OF CONTENTS

PART I

ITEM 1.~~BUSINESS~~ BUSINESS.

4We began the year 2015 as a start-up, internet-based eCommerce company that has historically offered and sold a new natural energy and health drink called Active UpLift® in two different flavors and also, an energy spray called All-Day Energy Spray® and subsequently, we contemplated launching new projects surrounding the energy drink, EpiGaia™, as well as selling through our website, www.upliftnutritioninc.com, products known as Tonify, X-Mint, Gray-to-Great and a product called Mitigator®.

While we have made several significant contacts in the retail food business over the last several years, we were unable to seriously launch Active UpLift ® or All-Day Energy Spray® in any national convenience or other large food chain stores for want of advertising capital. Due to the fact that we were unable to generate substantial advertising capital in some fashion or raise sufficient funds through the sale of our securities, we ceased operating our business in 2015. The Company is continuing today to raise new capital and new management is continuing to seek to acquire a new business, either through acquisition or merger.

Current Status of the Company

We are not presently involved in any bankruptcy or insolvency proceeding of any kind and none of our officers and directors has been involved, directly or indirectly, in any bankruptcy or similar proceeding. Neither we nor any officer or director is involved in any pending litigation, nor is any litigation involving us or any officer or director threatened.

We have no subsidiaries or properties other than the products we have developed and on which we have obtained various intellectual property protections. We also have several products that we are not currently marketing or not aggressively marketing.

We are not involved in any joint venture with any other party. Along with our current distributer agreement with Healthy Life, we entered into distribution agreement with Shanna Wrapp & Associates. This was to set up retail outlets and otherwise provide her with particular outlets on a wholesale basis. We are always continuing to look at whether we can enter into any advertising, marketing and vendor distribution agreements with various retailers and on what terms. This is something that we are doing on an on-going basis in the ordinary course of our business. In 2015, we ceased our relationship with Shanna Wrapp & Associates.

As set forth in our balance sheet in Part II below, as of December 31, 2015, we had no cash and no product inventory. All previously held inventory has been written off due to obsolescence and also, due to our current and recent efforts to focus on the sale of Tonify, X-Mint, Gray-to-Great, and Mitigator®, all as described in more detail below.

We maintain executive offices or facilities at the offices of our former majority shareholder located at 575 Riverside Avenue, Suite 102, Westport, CT 06880. We do not pay rent for these office facilities because their use is only nominal.

For and as of our year end, December 31, 2015, we had no revenues. We had zero dollars in deferred revenue representing sales for which the right of return has not been determined or expired. For and as of our fiscal year end, we ceased marketing, distribution and production of our products. These decisions were made, simply because we lacked working capital, as disclosed elsewhere herein. Also, control of the Company changed in June, 2015: see, Form 8-K filed with the Commission on June 8, 2015, which is incorporated herein by reference.

As of December 31, 2015, we had a net working capital deficiency of $13,898.

Our current stock transfer agent is Fidelity Transfer Company located at 8915 South 700 East, Suite 102, Sandy, Utah 84070, phone number 801-562-1300; fax number 801-233-0589.

As of December 31, 2015, we have approximately 1,248 shareholders of record. Fidelity Transfer Company has been our transfer agent since our initial public offering back in the 1950’s. We have but one class of stock issued and outstanding, that being common capital voting stock having a par value of $0.001 per share. Effective in December 2011, FINRA approved a 1 for 20 reverse split of common capital shares of which 100,000,000 common shares are authorized. A month prior thereto, effective November 21, 2011, the Secretary of State of the State of Nevada accepted an amendment to our Articles authorizing the issuance of as many as 10 million preferred shares, having a par value of $0.001 per share, the same as our common stock. No such shares have been issued nor are any currently outstanding. The rights and preferences relating to such preferred shares are subject to the discretion of our Board of Directors and the parameters are set forth in a Certificate of Designation filed with the State of Nevada on November 21, 2011. This was disclosed in a 14C Information Statement we filed on the SEC’s Edgar database in November 2011 and which was mailed out to our stockholders at that time.

In the November 21, 2011 amendments to our Articles, we also amended our Articles to allow our Board of Directors, if they so desire, to adopt or craft an employee stock option or other benefit plan in their discretion, a plan or program that would not require further shareholder approval. Reference is made to our filings with the State of Nevada which are available on the Secretary of State of Nevada’s website. Such documents are also available to a shareholder of record on request.

Of the 46,892,597 common shares issued and outstanding as of December 31, 2015, our officers and directors and majority shareholder own and hold or control, directly and indirectly, a total of 44,476,140 shares. This figure represents approximately 95% percent of our total number of issued common shares. See Item 12 of Part III below.

Principal Products or Services Previously Offered and Their Markets

Active Uplift®, Tonify, X-Mint; Gray to Great, Mitigator and All Day Energy Spray®

As a result of winding down our marketing efforts with respect to our products, we had no sales revenue in 2015. With respect to our products, Active UpLift® and All Day Energy Spray®, Tonify, and X-Mint, Gray-to-Great and Mitigator, we ceased all marketing, distribution and production during 2015.

Government Regulation and Need for Governmental Approval of Principal Products or Services

With respect to our products and distribution, these activities ceased during 2015

Applicability and Impact of Sales Taxes

Not Applicable.

Competition, Marketing Data and Information

During 2015, we ceased marketing, distribution and production of our products Tonify, X-Mint, Gray-to-Great and Mitigator®’.

Sources and Availability of Raw Materials and Names of Principal Suppliers

Not applicable

Dependence on One or a Few Major Customers

None; not applicable.

Patents, Trademarks, Licenses, Franchises, Concessions, Royalty Agreements or Labor Contracts

Though we have a registered federal trademark or trade name of the two phrases Active Uplift® and All Day Energy Spray®, both of which represent product that we own, we ceased marketing these products during 2015. The intellectual property protection that we therefore have on these products is no longer relevant.

Because we don’t own or license them, we have no intellectual property protection or rights with respect to the 4 products we previously sold through our website, namely, Tonify, X-Mint, Gray-to-Great and Mitigator®.

We currently have no franchises, concessions, royalty agreements or labor contracts. See also Item 2 of this Part immediately below titled “PROPERTIES.” Because we are no longer actively marketing these products, we are not aware of the current status of our various trademark and trade name applications and properties.

Research and Development Costs during the Last Two Fiscal Years

During the years ended December 31, 2015 and December 31, 2014, we expended no money towards research and development.

Costs and Effects of Compliance with Environmental Laws

None; not applicable.

Reports to Shareholders

None.

Employees

We currently have no employees and do not anticipate having to hire any other than possibly for part time clerical help. Accordingly, we have no immediate plans to retain employees until such time as our business plans warrant or justify the expense. We may find it necessary to periodically hire part-time clerical help on an as-needed basis though we have no plans to do so at this time.

Facilities

We are currently using as our principal place of business and office address 575 Riverside Avenue, Suite 102, Westport, CT 06880.

We have no written agreement with such persons and pay no rent for the use of this facility.

Additional Information

For more detailed information on our business and business plans, reference is made to ITEM 7 below titled “MANAGEMENT'’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION AND RESULTS OF OPERATIONS.”

We are subject to the information reporting requirements of the Securities Exchange Act of 1934 (the "Exchange Act"), and, in accordance therewith, we file reports and other information with the Commission. Reports and other information filed by the issuer with the Commission can be inspected and copied at the Commission's Public Reference Library in the Commission's own building located at 100 F Street, N.E., Washington, D.C. 20549. Copies of such material can be obtained from the Public Reference Section of the Commission at prescribed rates. An interested person may also obtain information about the operation of the Public Reference Room by calling the Commission at 1-800- SEC-0330. Inasmuch as we are an electronic filer, and the Commission maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the Commission, an interested person may access this material electronically by means of the Commission's home page on the Internet at www.sec.gov.com. To facilitate such access for an interested person, our CIK number is 0001390705.

ITEM 1A. RISK FACTORS

9Not applicable to smaller reporting companies.

ITEM 1B. UNRESOLVED STAFF COMMENTS

9 None; not applicable.

ITEM 2. PROPERTIES.

9We own all right, title and interest in and to our two health and energy products Active UpLift® and All Day Energy Spray®, none of which we are marketing at the present time. Other than as set forth in our license agreement with one of our former directors, we also own all right, title and interest in and to our “super juice ” EpiGaia™, a product that we are also not currently marketing. This interest is through an exclusive licensing agreement mentioned above with a former director. Finally, we own all right title and interest in and to our “Green Tea Diet” drink that we have also been holding off from marketing at the present time.

~~ITEM~~As set 3forth in the section above titled Patents, Trademarks, Licenses, Franchises, Concessions, Royalty Agreements or Labor Contracts,” we have a federal trade name and trademark on the phrase Active UpLift® which we obtained in 2008. During our ~~LEGAL~~2009 ~~PROCEEDINGS~~fiscal year, we received notice from our intellectual property attorneys that our application with the U.S. Patent and Trademark Office for a trade name and trademark on the phrase All Day Energy Spray® had issued and is now registered. This enabled us to put the capital “R” with a circle around it next to the name of both of these products, something that we have routinely done on all of our shipping packages and boxes used in interstate commerce.

10We have no proprietary or other interest in the four (4) products we ceased marketing on our website, namely, Tonify, X-Mint, Gray-to-Great and Mitigator®.

As disclosed elsewhere herein, in 2015, we ceased offering Tonify and X-Mint for sale because (1) they have not sold well and (2) inventory for those two products was difficult to maintain during 2015 due to lack of working capital.

Executive Offices

As of December 31, 2015, we maintained offices at 575 Riverside Avenue, Suite 102, Westport, CT 06880. We pay no rent for the use of this office space.

ITEM 3. LEGAL PROCEEDINGS

None.

ITEM 4. MINE SAFETY DISCLOSURES

10None; not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

~~MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES~~ Market Information

10As per information obtained from the OTC Markets Group, Inc. (www.otcmarkets.com), the price and trading activity in our stock for each quarter of fiscal 2015 and 2014 is set forth below.

Bid information*

	High Bid*		Low Bid*
	($)		($)
Year Ended December 31, 2015
Fourth quarter ended December 31, 2015	$	0.0400		0.0400
Third quarter ended September 30, 2015	$	0.0400		0.0400
Second quarter ended June 30, 2015	$	0.0401		0.0400
First quarter ended March 31, 2015	$	0.0800		0.0311
Fiscal Year Ended December 31, 2014
Fourth quarter ended December 31, 2014	$	0.0511		0.0300
Third quarter ended September 30, 2014	$	0.1000		0.0300
Second quarter ended June 30, 2014	$	0.3000		0.0042
First quarter ended March 31, 2014	$	0.2500		0.0042

* The quotations do not reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

Penny Stock

The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a market price of less than $5.00, other than securities registered on certain national securities exchanges, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock, to deliver a standardized risk disclosure document prepared by the SEC, that: (a) contains a description of the nature and level of risk in the market for penny stocks in both public offerings and secondary trading; (b) contains a description of the broker's or dealer's duties to the customer and of the rights and remedies available to the customer with respect to a violation of such duties or other requirements of the securities laws; (c) contains a brief, clear, narrative description of a dealer market, including bid and ask prices for penny stocks and the significance of the spread between the bid and ask price; (d) contains a toll-free telephone number for inquiries on disciplinary actions; (e) defines significant terms in the disclosure document or in the conduct of trading in penny stocks; and (f) contains such other information and is in such form, including language, type size and format, as the SEC shall require by rule or regulation.

The broker-dealer also must provide, prior to effecting any transaction in a penny stock, the customer with (a) bid and offer quotations for the penny stock; (b) the compensation of the broker-dealer and its salesperson in the transaction; (c) the number of shares to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the market for such stock; and (d) a monthly account statement showing the market value of each penny stock held in the customer's account.

In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from those rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written acknowledgment of the receipt of a risk disclosure statement, a written agreement as to transactions involving penny stocks, and a signed and dated copy of a written suitability statement.

These disclosure requirements may have the effect of reducing the trading activity for our common stock should our stock ever be traded on a public market. Therefore, stockholders may have difficulty selling our securities.

As of our year end, there were a total of 46,892,597 shares issued and outstanding. For more information on who owns our stock and what stock may trade without restriction, see Item 12 of Part III below titled “SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.”

As stated above, we currently have no outstanding warrants, options, incentive stock option or employee compensation plans of any kind or nature. As disclosed above, however, our Board of Directors now has the power and authority under our Amended Articles filed with the Secretary of State of Nevada in November 2011 to craft an incentive stock option or employee compensation plan if it so desires without further shareholder approval. At the same time, and though there are currently no plans to do so, no assurance can be given that such derivative securities will not be issued in the future, particularly if there is a good business reason to do so. We do have a convertible note outstanding in favor of our majority shareholder that can be converted into common stock. It is similar to a revolving line of credit. As he advances more money, there is more debt that can be converted to stock. This convertible note was assigned to our majority shareholder on September 6, 2013 from a former majority shareholder.

In July 2014, Mr. Deworth Williams, our majority shareholder, sold or conveyed the portion of the Convertible Note that he acquired from Uplift Holdings, LLC (“Uplift Holdings”) in September 2013, to Mr. Edward F. Cowle. At the time that Mr. Williams acquired the Note, it had a face value of approximately $60,000. The face amount of the Note as acquired from Uplift Holdings was thus assigned to Mr. Cowle. Mr. Williams has advanced us additional funds to us since September of 2013, thereby adding to the Note over the last year to the extent of approximately $41,000 as of the end of our fiscal year. In his partial assignment to Mr. Cowle, Mr. Williams retained that portion of the Note that he added within the last year.

During calendar year 2015 and as disclosed elsewhere in this report, due to lack of funding, we ceased all of our prior business activities. Accordingly, management of the Company began considering acquiring the business or equity of another entity without the Company paying any material amount of cash consideration (a “Reverse Merger Transaction”). Any Reverse Merger Transaction may be structured as an acquisition of assets or equity by the Company issuing stock, exchanging stock and other equity interests, merging with another entity or entities or entering into any transaction with similar effect. In connection with any Reverse Merger Transaction, the Company will likely assume the obligations of the acquired business, which may include debt or other financing, and may incur other debt or other financing. The amount of stock that the Company may issue in any Reverse Merger Transaction will likely result in a change in control of the Company. No assurances can be given, however, that we will identify a suitable acquisition target or that if we do, that we can negotiate and/or consummate a transaction with terms favorable to the Company and its shareholders.

Stock Purchase Agreement

On June 8, 2015, pursuant to a Stock Purchase Agreement dated as of June 4, 2015 (the “SPA”) by and among, among others, Edward F. Cowle, H. Deworth Williams (“HD Williams”) and Geoff Williams (each a “Seller,” and, collectively, the “Sellers”), and MCB Network, Corp., a Texas corporation (“MCB”), the Sellers sold (the “Share Block Acquisition”) to MCB, 9,476,150 shares (the “Shares”) of restricted common stock, par value $0.001 per share (the “Common Stock”) of Uplift Nutrition, Inc., a Nevada Corporation (the “Company” or the “Registrant”), owned by the Sellers for an aggregate purchase price of $135,509. H.D. Williams is a stockholder, affiliate and control person of the Registrant and Geoff Williams is a stockholder, executive officer, director, control person and affiliate of the Registrant.

Cowle Note Purchase and Conversion Agreement

On June 8, 2015, pursuant to a Note Purchase and Conversion Agreement dated as of June 4, 2015 (the “Cowle NPA”), by and among others, Mr. Cowle and five (5) purchasers (each a “Cowle Note Purchaser,” and collectively the “Cowle Note Purchasers’”), each Cowle Note Purchaser purchased (the “Cowle Note Acquisition”), a portion of the $67,027 outstanding amount of the convertible promissory note of the Registrant owned by Mr. Cowle the (“Cowle Note”). Simultaneously with the closing of the Share Block Acquisition, the Williams Note Acquisition (as defined below), and the Cowle Note Acquisition (collectively the “Transaction”), each portion of the Cowle Note purchased by a Cowle Note Purchaser automatically converted, pursuant to the terms of the Cowle NPA, into restricted shares of common stock, which in the aggregate resulted in the issuance to the Cowle Note Purchasers of 23,000,000 restricted shares of common stock of the Registrant and, thereafter, the Cowle Note was cancelled.

H.D. Williams Note Purchase and Conversion Agreement

On June 8, 2015, pursuant to a Note Purchase and Conversion Agreement dated as of June 4, 2015 by and among others, HD Williams and the eleven (11) purchasers (each an “HD William Note Purchaser,” and collectively, the “Williams Note Purchasers,” and together with MCB, as the purchaser of the 9,476,150 Shares pursuant to the SPA, and the Cowle Note Purchasers, collectively, the “Purchasers”), named therein (the “Williams NPA,” and together with the Cowle NPA and the SPA, collectively, the “Transaction Agreements”), each Williams Note Purchaser purchased a portion of the $51,061 outstanding amount of the convertible promissory note of the Registrant owned by HD Williams (the “Williams Note”), for an aggregate purchase price of $51,061 (the “Williams Note Acquisitions”). Simultaneously with the closing of the Transaction, each portion of the Williams Note purchased by a Williams Note Purchaser automatically converted, pursuant to the terms of the Williams SPA, into restricted shares of the Registrant’s common stock, which in the aggregate resulted in the issuance to the Williams Note Purchasers of 10,000,000 shares of restricted common stock and, thereafter, the Williams Note was cancelled.

Immediately prior to the closing of the Transaction, the Registrant had issued and outstanding 13,892,597 shares of common stock; and immediately following the closing of the Transaction the Registrant had issued and outstanding 46,892,597 shares of common stock, which increase resulted from the issuance of an aggregate of 33,000,000 restricted shares issued by the Registrant to the Cowle Note Purchasers and the Williams Note Purchasers upon the automatic conversion of the Cowle Note and the Williams Note on the closing date of the Transaction pursuant to the Cowle NPA and the Williams NPA, respectively.

As a condition to the closing of the Transaction, each Purchaser (including MCB) executed in favor of Sharon Will, who may be deemed a control person of MCB and the Registrant, an Irrevocable Proxy and Lock-Up Agreement (each an “Irrevocable Proxy,” and, collectively, the “Irrevocable Proxies”), pursuant to which each Purchaser (i) provided Ms. Will the right to vote, and (ii) agreed not to sell, transfer and/or otherwise dispose of, any of such Purchaser’s shares of common stock until the date three (3) business days following the date the Registrant files with the SEC a Current Report on Form 8-K with Form 10 type information disclosing an acquisition by the Registrant of a business (an “Acquisition 8-K”).

In connection with and as a condition to the closing of the Transaction, each of H.D. Williams, Mr. Cowle, Geoff Williams, Rachel Winn, a director of the Registrant, and certain other persons provided a General Release in favor of, depending on the person giving the release, among other persons, the Registrant, MCB, the Purchasers and all of their respective officers, directors, affiliates and successors.

Pursuant to the terms of the Transaction Agreements, on July 17, 2015, ten (10) days after the mailing to the Registrant’s shareholders (the “Schedule 14 Information Statement Effective Date”) of a Schedule 14F-1 Information Statement (the “Schedule 14 Information Statement”), pursuant to Section 14F and Rule 14f-1 thereunder of the Securities Exchange Act of 1934, as amended (the “1934 Act”), (i) the previously provided resignations of the two (2) current officers and directors of the Registrant (Geoff Williams and Ms. Winn) as officers and directors of the Registrant, and (ii) the prior “subject to” appointments by the Registrant’s Board of Directors of Ms. Will and Fred Richman, as the sole directors of the Registrant, became effective automatically resulting in Ms. Will and Mr. Richman becoming the sole directors of the Registrant and Ms. Will and Mr. Richman have indicated that on the Schedule 14 Information Statement Effective Date it is their intention, as the newly constituted Board of Directors, of the Registrant, to appoint Ms. Will as the president, secretary and treasurer of the Registrant. In addition, the reconstituted Board may thereafter also appoint other directors and executive officers to the Registrant.

Registration Rights

Pursuant to the Cowle Agreement, each of the Cowle Note Purchasers received registration rights requiring the Registrant to use its commercially reasonable efforts to (i) file a registration statement with the SEC covering the resale of each such Cowle Note Purchaser’s portion of the 23,000,000 restricted shares of common stock previously issued to the Cowle Note Purchasers upon the automatic conversion of the Cowle Note, no later than sixty (60) days following the date the Registrant files with the SEC an Acquisition 8-K (the “Filing Date”), and (ii) thereafter, have such registration statement declared effective by the SEC as soon as possible. In addition, each Cowle Note Purchaser received certain piggy-back registration rights with respect to each such person’s portion of the 23,000,000 shares, subject in all instances to certain cut-backs.

Payments to Third Party

Pursuant to the SPA, the Sellers, at the closing of the Transaction (i) paid $30,000, and (ii) sold $1,404 of the Cowle Note which converted into 1,300,000 restricted shares of common stock, to a third party retained by the Sellers in connection with the Transaction.

The foregoing descriptions of the Transaction, the SPA, the Cowle NPA and the Williams NPA and the transactions described therein, are qualified in their entirety by reference to the SPA, the Cowle NPA and the Williams NPA, respectively, each of which is attached as an Exhibit to Registrant’s Form 8-K filed with the Commission on June 12, 2015.

Having obtained an OTCBB symbol as long ago as 2007, there are, and have been, no plans, proposals, arrangements or understandings with any person, including any securities broker-dealer or anyone associated with a broker-dealer, concerning the development of a trading market in our common capital stock on the OTCBB or OTCQB, the latter of which is quoted through www.otcmarkets.com. Moreover, we have had no discussions with anyone, to date, in this regard.

Holders

According to our stock transfer agent, Fidelity Transfer Company, as of the date of this annual report, there are approximately 1,248 holders of record of our common capital stock.

Dividends and Dividend Policy

Our Board of Directors has NOT declared or paid cash dividends or made distributions in the past and we do not anticipate that we will pay cash dividends or make distributions to shareholders in the foreseeable future. We currently intend to retain and invest future earnings, if any, to finance our operations.

The holders of our common stock are entitled to receive such lawful dividends as may be declared by the Board of Directors. As of this date, no such dividends have been declared and based on our current need for advertising capital; management does not believe it likely that dividends will be declared in the near or distant future. The payment of any future dividends will depend upon, among other things, future earnings, capital requirements, our financial condition and general business conditions. As a result, there can be no assurance that any dividends on common stock will be paid in the future. We also have no redemption or sinking fund provisions applicable to any shares of common stock.

Description of Securities

Our authorized capital stock consists of 100,000,000 shares of common capital stock, $0.001 par value, of which 46,892,597 shares were issued and outstanding as of our fiscal year-end, December 31, 2015. During February 2014, 200,000 shares were issued to a former director and officer as compensation for services rendered. As also disclosed above, as a result of the November 2011 amendments to our Nevada Articles, our capital stock also consists of an additional 10 million preferred shares which we authorized, having a par value of $0.001 per share, of which none are currently issued or outstanding, the preferences and rights concerning which have not as yet been determined by our Board of Directors. See Exhibit 3.2 hereto referenced in Part IV, Item 15 below.

As of our December 31, 2015, year-end, including the date of this Annual Report, there are NO options, warrants, stock appreciation rights, or other rights of a similar nature outstanding which currently obligate us to issue any additional common stock to anyone. Our common stock is considered a "penny stock" because it meets, or would meet, if and when it trades, one or more of the definitions in Commission Rule 3a51-1 of the Exchange Act. These include but are not limited to the following: (i) the stock trades at a price less than five dollars ($5.00) per share; (ii) it is NOT traded on a "recognized" national exchange; (iii) it is NOT quoted on the FINRA’s automated quotation system (NASDAQ), or even if so, has a price less than five dollars ($5.00) per share; OR (iv) is issued by a company with net tangible assets less than $2,000,000, if in business more than three years continuously, or $5,000,000, if in business less than a continuous three years, or with average revenues of less than $6,000,000 for the past three years. The principal result or effect of being designated a "penny stock" is that securities broker-dealers cannot recommend the stock but must trade in it on an unsolicited basis.

Section 15(g) of the Securities Exchange Act of 1934, as amended, and Rule 15g-2 promulgated there under by the Commission require broker-dealers dealing in penny stocks to provide potential investors with a document disclosing the risks of penny stocks and to obtain a manually signed and dated written receipt of the document before effecting any transaction in a penny stock for the investor's account. These rules may have the effect of reducing the level of trading activity in the secondary market, if and when one develops.

Potential investors in our common stock are urged to obtain and read such disclosures carefully before purchasing any shares that are deemed to be "penny stock." Moreover, Commission Rule 15g-9 requires broker-dealers in penny stocks to approve the account of any investor for transactions in such stocks before selling any penny stock to that investor. This procedure requires the broker-dealer to (i) obtain from the investor information concerning his or her financial situation, investment experience and investment objectives; (ii) reasonably determine, based on that information, that transactions in penny stocks are suitable for the investor and that the investor has sufficient knowledge and experience as to be reasonably capable of evaluating the risks of penny stock transactions; (iii) provide the investor with a written statement setting forth the basis on which the broker- dealer made the determination in (ii) above; and (iv) receive a signed and dated copy of such statement from the investor, confirming that it accurately reflects the investor's financial situation, investment experience and investment objectives. Pursuant to the Penny Stock Reform Act of 1990, broker- dealers are further obligated to provide customers with monthly account statements.

Compliance with the foregoing requirements may make it more difficult for investors in our stock to not only buy but to resell their shares to third parties or to otherwise dispose of them in the market or otherwise.

We are informed that the Financial Industry Regulatory Authority (FINRA) issued certain rules or regulations in early 2009 relative to depositing physical certificates in a brokerage account, among other things. We are not familiar with these new rules or regulations as they do not affect us directly but we would encourage a shareholder or interested person to contact his or her stock brokerage firm to determine if these new rules and regulations affect such person.

Common Capital Stock

The holders of our common stock are entitled to one (1) vote per share on all matters submitted to a vote of the shareholders. In addition, such holders are entitled to receive ratably such dividends, if any, as may be declared from time to time by the board of directors out of funds legally available for such purpose. In the event of dissolution, liquidation or winding-up, the holders of common stock are entitled to share ratably in all assets remaining after satisfaction of all our liabilities, subject, of course, to the prior distribution rights of any preferred stock that may be outstanding at that time. The holders of common stock do not have cumulative voting rights or preemptive or other rights to acquire or subscribe for additional, unissued or treasury shares, which means that the holders of more than 50% of such outstanding shares voting at an election of directors can elect all the directors on the board of directors if they so choose and, in such event, the holders of the remaining shares will not be able to elect any of the directors.

Because the rights and preferences to our newly authorized preferred shares have not been designated, we can make no representations at the present time as to whether they will involve or represent more than one (1) common share vote per preferred share, for example, on matters to be acted upon.

Preemptive Rights, Cumulative Voting and Control

Under Nevada law, if a corporation does not expressly allow, in its Articles, for preemptive rights, no such rights are authorized. When we re-incorporated in Nevada back in 2006, our Articles did not expressly provide for any such rights. That is to say, no shareholder has the right to acquire stock from us on any set of terms before that same stock is offered to another person. This is the definition of "preemptive rights." In addition, as set forth in the previous paragraph, cumulative voting in electing directors is similarly not authorized by our Articles of Incorporation. Accordingly, the holder(s) of a majority of our outstanding shares, present in person or by proxy, will be able to elect all of directors at a meeting called for such purpose.

Liquidation Rights

In the event of liquidation, dissolution or a winding up of us or our affairs, holders of common stock would be entitled to receive pro rata all of our remaining assets that are available and distributable to the shareholders after first satisfying claims of creditors and anyone else having rights that are superior to those of the common stockholders.

Securities Authorized for Issuance under Equity Compensation Plans

We have NOT authorized any securities for issuance under any equity or other compensation plans of any type or nature, inasmuch as we have NOT adopted any such incentive or compensation plans and have no intention, at present, to do so.

Recent Sales of Unregistered Securities

Please see Registrant’s Form 10-Q filed with the U.S. Securities and Exchange Commission on October 18, 2016, disclosing the sales by the Company of its unregistered securities, all of which is incorporated by reference herein.

Use of Proceeds of Registered Securities

None; not applicable.

Purchases of Equity Securities by Us and Affiliated Purchasers.

We did NOT purchase any of our own securities during the 2015 fiscal year.

Stock Transfer Agent

Fidelity Transfer Company ("Fidelity") is our stock transfer agent and has served as such since our initial public offering in the mid 1950’s. Fidelity is located at 8915 South 700 East, Suite 102, Sandy, Utah 84070, phone number 801-562-1300, fax number 801-233-0589.

ITEM 6. SELECTED FINANCIAL DATA

14Responding to this item is not required for smaller reporting companies.

~~ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION AND~~ 10

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

14MCB Network Corp. purchased the control block of voting common shares of Uplift Nutrition, Inc. ("Uplift" or the "Company") on June 12, 2015. At that time Uplift, a nutritional supplement sales company and web developer, operating several web sites for distribution of its products, ceased all of its business and transitioned to the media sector company. MCB Networks Corp. was a Spanish-language media entity that had Spanish content and distribution channels in several cities in the United States. Due to capital constraints, the business plan of MCB Network Corp. was not realized and plans to continue operations were discontinued, with several shareholders obtaining ownership of its control block of voting common shares with the intention of identifying and acquiring an alternative business for Uplift and its shareholders. Uplift is continuing today to raise new capital and new management is continuing to seek to acquire a new business, either through acquisition or merger. Accordingly, with a keen objective of growing and merging with a successful business in the very near future, Uplift continues to engage in discussions with potential acquisition candidates. As of December 31, 2015, MCB and control shareholders were discussing and planning a new business opportunity.

~~ITEM~~Our principal 7Abusiness plan up to and through the second quarter of the 2015 fiscal year has been to promote, market and sell Tonify, X-Mint, Gray-to-Great and Mitigator®, four new products, two of which we just started marketing, all as disclosed in Part II, Item 5 below. ~~QUANTATIVE~~See ~~AND~~our ~~QUALITATIVE~~website, ~~DISCLOSURES~~www.upliftnutritioninc.com. ~~ABOUT~~As ~~MARKET~~disclosed ~~RISK~~ above and elsewhere herein, we will ceased marketing, distribution and production of our products, including Tonify and X-Mint because (1) sales of those two products has not been what we anticipated and (2) we have difficulty keeping those products in inventory.

17Our Websites

~~ITEM~~During 2015, 8.we ~~FINANCIAL~~shut ~~STATEMENTS~~down ~~AND~~or ~~SUPPLEMENTRY~~discontinued ~~DATA~~ our former websites, www.upliftnutritioninc.com, www.epigaia.com, www.alldayenergyspray.com, and www.upliftenergy.com.

18Inventory

~~ITEM~~We no 9.longer ~~CHANGES~~carry INany ~~AND~~inventory ~~DISAGREEMENTS~~of ~~WITH~~any ~~ACCOUNTANTS~~of ONour ~~ACCOUNTING~~products ~~AND~~and as of December 31, 2015, we had no inventory.

~~FINANCIAL~~We are ~~DISCLOSURE~~ NOT Dependent on One Supplier for Our Potential Success

29Not Applicable

Our Business Plan over the Remainder of the Year

During 2015, we ceased all marketing, distribution and production of our products. Through the end of 2015, we started seeking new business opportunities.

Results of Operations

Years Ended December 31, 2015 and 2014

Loss from Operations - Continuing Operations

We did not recognize revenues for the years ended December 31, 2015 and 2014. During the year ended December 31, 2015, we recorded total operating expenses of $25,947. In the comparable period of 2014, we recorded operating expenses totaling $21,389.

Other Expenses - Continuing Operations

During the years ended December 31, 2015 and 2014 we recorded interest expense totaling $4,371 and $7,038, respectively. In addition, we recognized a loss on settlement of debt in the amount of $501,776, pursuant to the issuance of common stock for outstanding debts during the period ending December 31, 2015.

Net Loss - Continuing Operations

The above factors resulted in a net loss from continuing operations for the year ended December 31, 2015 in the amount of $532,094 ($0.02 per share), compared to net loss of $28,427 ($0.00 per share) for the year ended December 31, 2014.

For the year ended December 31, 2015, we reported a loss from discontinued operations of $1,911. For the year ended December 31, 2014, we reported net income from discontinued operations of $4,201.

Liquidity and Capital Requirements

Total assets at December 31, 2015 were $0, compared to $11,154, comprised of $10,499 in cash and $655 in assets held for sale at December 31, 2014. Total liabilities at December 31, 2015 were $13,898, consisting of $13,182 in accounts payable and accrued expenses and $716 in notes payable, net of debt discounts. At December 31, 2014, total liabilities were $117,447 consisting of $13,672 in accounts payable and accrued expenses, $2,463 in accrued interest due to related parties, $41,312 in related-party payables and $60,000 in notes payable.

Because we currently have no revenues and limited available cash, for the immediate future we believe we will have to rely on potential advances from stockholders to continue to search for new business opportunities. There is no assurance that our stockholders will continue indefinitely to provide additional funds or pay our expenses. It is likely the only other source of funding future operations will be through the private sale of our securities, either equity or debt.

At December 31, 2015, we had stockholders’ deficit of $13,898 compared to stockholders’ deficit of $106,293 at December 31, 2014. The decreased deficit is primarily due to the issuance of common stock to satisfy outstanding debts.

As of our fiscal year ended December 31, 2015, we had no cash. What we have in our checking or bank account at any given time is insignificant inasmuch as our working capital has historically been provided by our shareholders.

We hope to be able to satisfy our cash requirements for at least the next 12 to 18 months by offering and selling our debt and equity securities. Notwithstanding our intentions to seek working capital through exempt securities placements, we cannot be assured that any such securities’ transactions will occur.

Our Budget over the Next 12 Months

Due to our cessation of our product advertising and distribution during 2015, we are in discussions with various parties and seeking new business opportunities. Accordingly, we cannot currently estimate our budget requirements or time requirements for the next calendar year.

Contingency Planning

Not applicable.

Off-Balance Sheet Arrangements

None; not applicable.

Effect of Current Economic Conditions

Obviously, current economic conditions are hurting all businesses, not to mention retail outlets and retail sales overall. Since we have ceased the marketing, distribution and production of our products during 2015, we have been seeking new business opportunities. Nonetheless, the current economic conditions will continue to depress markets and we can provide no assurances that even if we enter a new business opportunity that the same will succeed.

PLAN OF OPERATION

As stated elsewhere herein, our plan is to seek new business opportunities.

Shipping of Our Products

Not applicable.

Inventory

Not applicable.

Our On-Line Marketing/Advertising Strategy

Not applicable

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

No response to this item is required for smaller reporting companies.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of Uplift Nutrition, Inc.

We have audited the accompanying balance sheets of Uplift Nutrition, Inc. (“the Company”) as of December 31, 2015 and 2014, and the related statements of operations, stockholders’ deficit, and cash flows for each of the years in the two year period ended December 31, 2015. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Uplift Nutrition, Inc. as of December 31, 2015 and 2014, and the results of its operations and its cash flows for each of the years in the two year period ended December 31, 2015, in conformity with accounting principles generally accepted in the United States of America.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company has incurred accumulated losses and a working capital deficit as of December 31, 2015 which raises substantial doubt about its ability to continue as a going concern. Management’s plans concerning these matters are also described in the footnotes to the consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ Sadler, Gibb & Associates, LLC

Salt Lake City, UT

January 19, 2017

F-1

UPLIFT NUTRITION, INC.
BALANCE SHEETS

	December 31,			December 31,
	2015			2014

ASSETS

CURRENT ASSETS:
Cash	$	-		$	10,499
Assets held for sale		-			655
Total Current Assets		-			11,154

TOTAL ASSETS	$	-		$	11,154

LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES:
Accounts payable and accrued expenses	$	13,182		$	13,672
Accrued interest payable - related party		-			2,463
Due to related parties		-			41,312
Notes payable		-			60,000
Convertible notes payable – related party, net of discount of $1,284 and $0, respectively		716			-
Total Current Liabilities		13,898			117,447

TOTAL LIABILITIES		13,898			117,447


STOCKHOLDER'S DEFICIT
Common stock, $0.001 par value; 100,000,000 shares authorized, 46,892,597 and 13,892,597 shares issued and outstanding, as of December 31, 2015 and December 31, 2014, respectively		46,893			13,893
Additional paid-in capital		2,078,552			1,485,152
Accumulated deficit		(2,139,343	)		(1,605,338	)
TOTAL STOCKHOLDERS' DEFICIT		(13,898	)		(106,293	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	-		$	11,154

The accompanying notes are an integral part of these financial statements.

F-2

UPLIFT NUTRITION, INC.
STATEMENTS OF OPERATIONS

	For the Years Ended December 31,
	2015			2014

NET REVENUES	$	-		$	-

OPERATING EXPENSES
Legal and professional fees		18,216			20,434
General and administrative		7,731			955
Total operating expenses		25,947			21,389

LOSS FROM OPERATIONS		(25,947	)		(21,389	)

OTHER EXPENSE
Interest expense - related party		(4,371	)		(7,038	)
Loss on settlement of debt		(501,776	)		-
TOTAL OTHER EXPENSE		(506,147	)		(7,038	)

NET LOSS FROM CONTINUING OPERATIONS		(532,094	)		(28,427	)

(LOSS) INCOME FROM DISCONTINUED OPERATIONS, NET OF TAX		(1,911	)		4,201

NET LOSS	$	(534,005	)	$	(24,226	)

BASIC AND DILUTED LOSS PER SHARE
Continuing operations	$	(0.02	)	$	(0.00	)
Discontinued operations		(0.00	)		(0.00	)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING – BASIC AND DILUTED		32,517,255			13,869,583

The accompanying notes are an integral part of these financial statements.

F-3

UPLIFT NUTRITION, INC.

STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT

FOR THE YEARS ENDED DECEMBER 31, 2015 AND 2014

										Total
	Common Stock				Additional		Accumulated			Stockholders'
	No. of Shares		Value		Paid-in Capital		Deficit			Equity (Deficit)
Balance at December 31, 2013		13,692,597	$	13,693	$	1,484,512	$	(1,581,112	)	$	(82,907	)
Issuance of common stock for services		200,000		200		640		-			840
Net Loss		-		-		-		(24,226	)		(24,226	)
Balance at December 31, 2014		13,892,597		13,893		1,485,152		(1,605,338	)		(106,293	)
Issuance of common stock for the conversion of convertible debt		33,000,000		33,000		591,400		-			624,400
Discount related to convertible note payable		-		-		2,000		-			2,000
Net loss		-		-		-		(534,005	)		(534,005	)
Balance at December 31, 2015	$	46,892,597	$	46,893	$	2,078,552	$	(2,139,343	)	$	(13,898	)

The accompanying notes are an integral part of these consolidated financial statements.

F-4

UPLIFT NUTRITION, INC.
STATEMENTS OF CASH FLOWS

	For the Years Ended December 31,
	2015			2014

OPERATING ACTIVITIES
Net loss	$	(534,005	)	$	(24,226	)
Adjustment to reconcile change in net loss to net cash from operating activities:
Net (income) loss from discontinued operations		1,911			(4,201	)
Loss on settlement of debt		501,776			-
Stock issued for services		-			840
Amortization of debt discount		716			-
Changes in operating assets and liabilities:
Accounts payable and accrued expenses		11,404			4,907
Accrued interest – related party		1,655			7,038

NET CASH USED IN CONTINUING OPERATING ACTIVITIES		(16,543	)		(15,642	)
NET CASH (USED IN) PROVIDED BY DISCONTINUED OPERATING ACTIVITIES		(1,256	)		3,659
NET CASH USED IN OPERATING ACTIVITIES		(17,799	)		(11,983	)

FINANCING ACTIVITIES
Proceeds from related party payable		7,300			-
Bank overdraft		-			-
Net advances from shareholders		-			19,501

NET CASH PROVIDED BY CONTINUING FINANCING ACTIVITIES		7,300			19,501
NET CASH PROVIDED BY DISCONTINUED FINANCING ACTIVITIES		-			-
NET CASH PROVIDED BY FINANCING ACTIVITIES		7,300			19,501

Net decrease in cash and cash equivalents		(10,499	)		7,518

Cash at beginning of year		10,499			2,981

Cash at end of year	$	-		$	10,499

SUPPLEMENTAL CASH FLOW INFORMATION:

Stock issued for conversion of debt & accrued interest	$	122,624		$	-
Issuance of convertible note payable to related party for accounts payable paid on behalf of Company	$	2,000		$	-
Discount on convertible note payable – related party	$	2,000		$	-

The accompanying notes are an integral part of these financial statements.

F-5

Uplift Nutrition Inc.

Notes to Consolidated Financial Statements

December 31, 2015

NOTE 1 – ORGANIZATION AND BUSINESS

Uplift Nutrition, Inc. (“the Company”), a Nevada corporation, was originally engaged in the business of manufacturing and distributing a nutritional supplement drink mix. The Company’s operations are based in Salt Lake City, Utah. The Company has, at the present time, not paid any dividends and any dividends that may be paid in the future will depend upon the financial requirements of the Company and other relevant factors.

On June 12, 2015, MCB Network Corp. purchased the control block of voting common shares of the Company. MCB Networks Corp. was a Spanish-language media entity that had Spanish content and distribution channels in several cities in the United States. Due to capital constraints, the business plan of MCB Network Corp. was not realized and plans to continue operations were discontinued, with several shareholders obtaining ownership of its control block of voting common shares with the intention of identifying and acquiring an alternative business for the Company. The Company is continuing today to raise new capital and new management is continuing to seek to acquire a new business, either through acquisition or merger.

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The financial statements of the Company have been prepared using the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”).

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated.

Cash and Cash Equivalents

The Company considers highly liquid investments that are readily convertible to known amounts of cash with original maturities of three months or less to be cash equivalents.

Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:

Level 1 Inputs – Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2 Inputs – Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.

Level 3 Inputs – Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities Financial instruments consist of cash and cash equivalents, accounts payable and borrowings. The fair value of current financial assets and current financial liabilities approximates their carrying value because of the short-term maturity of these financial instruments.

F-6

Uplift Nutrition Inc.

Notes to Consolidated Financial Statements

December 31, 2015

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (continued)

Income Taxes

An asset and liability approach is used for financial accounting and reporting for income taxes. Deferred income taxes arise from temporary differences between income tax and financial reporting and principally relate to recognition of revenue and expenses in different periods for financial and tax accounting purposes and are measured using currently enacted tax rates and laws. In addition, a deferred tax asset can be generated by net operating loss carryforwards (“NOLs”). If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized.

Loss Per Share

The Company calculates loss per share in accordance with FASB ASC 260. Basic earnings/loss per common share is based on the weighted average number of common shares outstanding during each period. Diluted earnings per common share are based on weighted average number of common shares outstanding during the period plus potentially dilutive common shares from common stock equivalents. The Company has 100,000 and 0 common stock equivalents as of December 31, 2015 and 2014, respectively, that were not included in the calculation of diluted loss per share as this effect would have been anti-dilutive.

Subsequent Events

The Company’s management reviewed all material events through the issuance date of this report for disclosure consideration.

Recent Accounting Pronouncements

In August 2014, the Financial Accounting Standards Board issued Accounting Standards Update 2014-15, Presentation of Financial Statements- Going Concern. The Update provides U.S. GAAP guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company’s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in this Update are effective for the annual period ended after December 15, 2016, and for annual periods and interim periods thereafter. The Company is currently evaluating the effects of ASU 2014-15 on the financial statements.

The Company does not expect the adoption of any other recent accounting pronouncements to have a material impact on its financial statements.

NOTE 3 – GOING CONCERN

The accompanying financial statements have been prepared in conformity with accounting principles, generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has sustained losses of $2,139,343 from June 7, 2005 (inception) through December 31, 2015, including a loss of $534,005 for the year ended December 31, 2015. Furthermore, the Company has recognized only minimal revenue since its inception, which raises substantial doubt about the Company’s ability to continue as a going concern.

In view of the matters described in the preceding paragraph, recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon continued operations of the Company, which in turn is dependent upon the Company's ability to meet its current obligations on a continuing basis, to obtain financing, to acquire additional capital from investors, and to succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence. The Company needs to obtain capital, either long-term debt or equity to continue the implementation of its overall business plan. The Company plans on pursuing the additional capital necessary to continue its overall business plan.

F-7

Uplift Nutrition Inc.

Notes to Consolidated Financial Statements

December 31, 2015

NOTE 4 – DISCONTINUED OPERATIONS

On June 12, 2015, MCB Network Corp. purchased the control block of voting common shares of the Company. At that time the Company ceased all of its business related to nutritional supplement sales and web developing and transitioned to the media sector company. Accordingly, all activity related to the impairment of the assets has been classified as discontinued operations.

The assets held for discontinued operations presented on the balance sheet as of December 31, 2014 consisted of the following:

	December 31,
	2014

ASSETS
CURRENT ASSETS:
Accounts receivable, net	$	300
Inventory		355
Total Current Assets		655

TOTAL ASSETS	$	655

The income (loss) from discontinued operations presented in the income statement for the year ended December 31, 2015 and 2014, consisted of the following:

	For the Year Ended December 31,
	2015			2014

Revenue	$	-		$	8,806
Operating expenses
Cost of sales		-			4,431
General and administrative		1,911			174
Total operating expenses		1,911			4,605
Net Income (Loss) from discontinued operations	$	(1,911	)	$	4,201

F-8

Uplift Nutrition Inc.

Notes to Consolidated Financial Statements

December 31, 2015

NOTE 5 – RELATED PARTY TRANSACTIONS

A shareholder of the Company has made multiple cash advances to the Company, beginning in the 2008 fiscal year and continuing through June 30, 2015. Through December 31, 2014 the advances totaled $41,312. During the six months ended June 30, 2015, the shareholder advanced an additional $6,000. On June 8, 2015 the entire $48,612 principal balance of the note, along with $4,047 in accrued interest was sold to various unrelated parties and converted into an aggregate of 10,000,000 shares of common stock. The common shares issued were valued at the market value of $0.04 per share. Pursuant to this transaction the note was satisfied in full, and the Company recognized a loss on settlement of debt in the amount of $347,342. See also Note 6 and 7.

NOTE 6 – NOTES PAYABLE

On July 3, 2014 a shareholder assigned $60,000 of the advances in the form of an unsecured Note Payable to another individual. On June 8, 2015 the entire $60,000 principal balance of the note, along with $9,966 in accrued interest was sold to various parties and converted into an aggregate of 23,000,000 shares of common stock. The common shares issued were valued at the market value of $0.04 per share. Pursuant to this transaction the note was satisfied in full, and the Company recognized a loss on settlement of debt in the amount of $154,434. An additional $695,600 was charged to additional paid-in capital, representing the value by which the shares issued exceeded the value of the debt converted by two individuals who became related parties, as they were owners of more than 10 percent of the Company’s common stock.

NOTE 7 – CONVERTIBLE NOTES PAYABLE – RELATED PARTY

On August 22, 2015, the Company issued a convertible note payable to Sean Martin for $2,000. The note bears 10% interest per annum and has a maturity date of August 22, 2016. The note is convertible at any time into shares of the Company’s common stock at a rate of $0.02 per share.

The fair value of the common stock on the date the note was issued was $0.04, creating an intrinsic value of $0.02, which created a beneficial conversion feature (“BCF”) of $2,000. The BCF was recorded as a debt discount. The debt discount is being amortized over the term of the debt. Amortization of the debt discount for the year ended December 31, 2015 was $716. The balance of debt discount as of December 31, 2015 is $1,284.

NOTE 8 – INCOME TAXES

The Financial Accounting Standards Board (FASB) has issued FASB ASC 740-10. FASB ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements. This standard requires a company to determine whether it is more likely than not that a tax position will be sustained will be sustained upon examination based upon the technical merits of the position. If the more-likely-than- not threshold is met, a company must measure the tax position to determine the amount to recognize in the financial statements. As a result of the implementation of this standard, the Company performed a review of its material tax positions in accordance with recognition and measurement standards established by FASB ASC 740-10.

Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

No tax benefits have been reported in the financial statements, because the potential tax benefits of the net operating loss carry forwards are offset by a valuation allowance of the same amount. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carryforwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carryforwards may be limited as to use in the future.

F-9

Uplift Nutrition Inc.

Notes to Consolidated Financial Statements

December 31, 2015

NOTE 8 – INCOME TAXES (continued)

At December 31, 2015 the Company had net operating loss carryforwards of approximately $1,072,000 which can be used to offset future federal and state taxable income which will expire in the following years:

Year Ended	Amount
2026	$	50,655
2027	$	106,310
2028	$	234,289
2029	$	227,456
2030-2035	$	453,303

Net deferred tax assets consist of the following components as of December 31, 2015 and 2014:

	Year Ended
	December 31, 2015			December 31, 2014
Deferred Tax Assets
Net Operating Loss Carryforwards	$	364,484		$	355,313
Deferred Tax Valuation Allowance		(364,484	)		(355,313	)

Total Deferred Tax Assets (Net)	$	-		$	-

The income tax provision differs from the amount of income tax determined by applying the U.S. federal and state income tax rates of 34% to pretax income from continuing operations for the years ended December 31, 2015 and 2014 due to the following:

	Year Ended
	December 31, 2015			December 31, 2014

Current Federal Taxes	$	-		$	-
Current State Taxes		-			-
Change in NOL Benefit		(9,172	)		(7,951	)
Non-Cash Interest		(308	)		-
Change in Valuation Allowance		9,480			7,951
Provision for Income Taxes	$	-		$	-

At December 31, 2015, the Company had no unrecognized tax benefits that, if recognized, would affect the effective tax rate.

The Company did not have any tax positions for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within the next twelve months.

F-10

Uplift Nutrition Inc.

Notes to Consolidated Financial Statements

December 31, 2015

NOTE 8 – INCOME TAXES (continued)

The Company includes interest and penalties arising from the underpayment of income taxes in the consolidated statements of operations in the provision for income taxes. As of December 31, 2015 and 2014, the Company had no accrued interest or penalties related to uncertain tax positions.

The tax years that remain subject to examination by major taxing jurisdictions are those for the years ended December 31, 2015, 2014 and 2013.

NOTE 9 – STOCKHOLDERS’ EQUITY

On February 11, 2014 the Company issued 200,000 shares of common stock to an officer and director for services rendered. The shares were valued at $0.0042 per share, resulting in an aggregate expense of $840.

As of December 31, 2014, the Company had 13,892,597 common shares issued and outstanding, and an additional 329,501 shares held by the Transfer Agent in reserve to satisfy shares issued through a lost instrument bond, should the holder of an outstanding certificate for stock in the original merger submit his shares in trade for shares in Uplift Nutrition, Inc. As of December 31, 2015 the Company has 46,892,597 common shares issued and outstanding.

On June 8, 2015 the Company issued an aggregate of 33,000,000 shares of common stock to various investors in conversion of $122,624 in outstanding debts. The shares were valued at approximately $0.04 per share, being the listed market price of the stock on the date of issuance. Pursuant to this transaction the debts were satisfied in full, and the Company recognized a loss on settlement of debt in the amount of $501,776.

As a result of the issuance of the 33,000,000 shares of common stock to the Note Purchasers discussed in Note 6 and Note 7, and the execution by all of the Purchasers, of an Irrevocable Proxy in favor of Ms. Sharon Will, and the private sale of 9,476,150 shares of common stock from the Purchasers to MCB Network, Corp. and Ms. Will, voting control of the Company shifted from the original note holders to MCB and Ms. Will.

NOTE 10 – SUBSEQUENT EVENTS

The Company has evaluated events occurring after the date of our accompanying balance sheets through the date the financial statement were filed:

Change in Officers and Directors

On February 4, 2016, Ms. Sharon Will resigned as the Company’s Director, President, Secretary, and Treasurer and Mr. Fred Richman resigned as the Company’s Director. Sean Martin was appointed as the Chief Executive Officer and sole Director of the Company as of February 4, 2016.

On June 13, 2016, the Board of Directors appointed David M. Baum as Director, Chief Financial Officer and Chief Operating Officer of the Company.

Issuance of Convertible Note Payable

On April 10, 2016, the Company issued a convertible note payable to David Baum for $25,000. The note bears 10% interest per annum and has a maturity date of April 10, 2017. The note is convertible at any time into shares of the Company’s common stock at a rate of $0.02 per share.

On July 21, 2016, the Company cancelled David Baum’s Note and issued a new revised Note with the July 1, 2016 offering.

Issuance of Convertible Notes and Restricted Common Shares

On July 1, 2016, the Company commenced an offering to sell up to a total of $125,000 of its securities in exchange for issuing to the investor a 12% original issue discount convertible notes with a 10% annual interest rate and shares of restricted common stock at a price of $0.0083 per share. The minimum amount for each subscription is $12,500.

F-11

Uplift Nutrition Inc.

Notes to Consolidated Financial Statements

December 31, 2015

NOTE 10 – SUBSEQUENT EVENTS (Continued)

The notes will mature and are due and payable one year from the date of issuance and bear an interest rate of 10% per annum, payable quarterly. They are convertible at the election of the holder into shares of the Company’s restricted common stock at a price of $0.02 per share. The conversion price was subsequently reduced to $0.001

The Notes are subject to certain “favored nations” adjustment provisions including: 1) a reduction in conversion price to be equal to the price per share of any newly issued securities during the period these Notes are outstanding; 2) the right to exchange the Note(s) for any new debt or equity financing while these Notes are outstanding at a 30% discount; 3) proportional adjustment of the conversion features of Notes for any stock dividend, reverse stock splits, reclassifications, or similar event; 4) adjustments for other dividends and distributions during period these Notes are outstanding; 5) adjustment for any reorganization, consolidation and/or merger. These provisions will require derivative accounting treatment for these notes.

As of the date of the filing, an aggregate amount of $125,000 of the Company’s securities have been sold to six accredited investors resulting in the issuance of $140,818 in convertible debt and 15,000,000 restricted shares of common stock.

Issuance of Common Stock for Services

On September 6, 2016, the Company entered into a consulting agreement with Ms. Sharon Will, the Company’s former Director, to assist the Company transition to its new operations. The Company agreed to issue Ms. Will 500,000 shares of common stock and valued those shares based on the market price on the agreement date of $0.072, recognizing $36,000 of consulting expense.

Issuance of Warrants for Services

On June 3, 2016, pursuant to an agreement with David Baum, the Company’s CFO and COO, the Company issued warrants to purchase 5,000,000 shares of common stock. The stock is exercisable for a period of 3 years at a price of $0.001 per share commencing six months after the date of the issue date. The Company will recognize $198,091 in stock based compensation ratably over the six month service period for the fair value of these warrants based on a Black-Scholes option-pricing model.

On June 3, 2016, pursuant to an agreement with Sean Martin, the Company’s CEO, the Company issued warrants to purchase 10,000,000 shares of common stock. The stock is exercisable for a period of 5 years at a price of $0.001 per share commencing six months after the date of the issue date. The Company will recognize $396,183 in stock based compensation ratably over the six month service period for the fair value of these warrants based on a Black-Scholes option-pricing model.

Issuance and Conversion of Convertible Note Payable

On August 16, 2016, the Board of Directors amended the conversion rate for the Sean Martin Note to $0.001 per share and approved the conversion of the Note in full.

On August 22, 2016, pursuant to a conversion notice, the Company issued 2,000,000 shares of common stock for the full conversion of this convertible note.

F-12

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

29Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of December 31, 2015, these disclosure controls and procedures were ineffective to ensure that all information required to be disclosed by us in the reports that we file or submit under the Exchange Act is: (i) recorded, processed, summarized and reported, within the time periods specified in the Commission’s rule and forms; and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There have been no material changes in internal control over financial reporting that occurred during the fourth fiscal quarter that have materially affected, or are reasonably likely to materially affect the Company’s internal control over financial reporting.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed by, or under the supervision of, the Chief Executive Officer and Chief Financial Officer and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Our evaluation of internal control over financial reporting includes using the COSO framework, an integrated framework for the evaluation of internal controls issued by the Committee of Sponsoring Organizations of the Treadway Commission, to identify the risks and control objectives related to the evaluation of our control environment.

Our management conducted an evaluation of the effectiveness of our internal control over financial reporting. Based on our evaluation, management concluded that our internal control over financial reporting was ineffective for both of our fiscal years ended December 31, 2015 and 2014, in which there was a material weakness due to the lack of sufficient financial reporting controls with respect to the ability to process complex accounting issues such as its debt extinguishment. A material weakness in internal control over financial reporting is defined by the Public Company Accounting Oversight Board’s Audit Standard No. 5 as a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of our financial reporting.

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation requirements by our registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the company to provide only management’s report in this annual report.

Internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent limitations, including the possibility of human error and circumvention by collusion or overriding of controls. Accordingly, even an effective internal control system may not prevent or detect material misstatements on a timely basis. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

ITEM 9B. OTHER INFORMATION

29 None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, ~~PROMOTERS~~ AND ~~CONTROL~~CORPORATE ~~PERSONS AND~~ GOVERNANCE

~~CORPORATE~~Executive Officers ~~GOVERNANCE~~ and Directors

30As disclosed in our Form 8-K filed with the Commission on June 12, 2015, our then directors and officers Geoff Williams and Rachel Winn, resigned as officers and directors, effective July 17, 2015, and Sharon Will and Fred Richman were appointed directors of the Company, with Ms. Will being appointed President, Treasurer and Secretary of the Company. On February 4, 2016, Sean Martin was appointed a Director and the President of the Company while Sharon Will resigned as a Director and officer and Fred Richman resigned as a Director of the Company. On June 13, 2016, David Baum was appointed a Director, Chief Financial Officer and Chief Operating Officer of the Company. Our directors, officers and “control persons” are as follows:

Name	Age	Position

Geoff Williams (1) – (Resigned)	44	Chairman of the Board, President, Chief Financial Officer

Rachel Winn (2) – (Resigned)	44	Director

Sharon D. Will (3) – (Resigned)	58	Director, President, Treasurer and Secretary

Fred Richman (4) – (Resigned)	70	Director

Sean Martin (5)	__	Director and President

David Baum (6)	__	Director, Chief Financial Officer and Chief Operating Officer

(1) Mr. Williams was a director of the Company since September 2013; and since September 2014, was the Company’s Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer. Since 1994, Mr. Williams has been a representative of and partner in Williams Investment Company, a Salt Lake City, Utah, financial consulting and corporate services firm involved in facilitating and structuring mergers, acquisitions, business consolidations and financings. Mr. Williams has been instrumental in negotiating well over thirty of these transactions, most of which have resulted in private companies going public, and subsequently being traded on various public exchanges. In addition, Williams has often arranged financings for these companies, as well as others. For numerous years he sat on the board, and was one of three founding principals of U.S. Rare Earths, Inc. (OTC BB: UREE ), a publicly-held mineral exploration company. Mr. Williams has been on the board of directors of several companies, most recently Protect Pharmaceutical Corporation (OTC BB: PRTT ). Mr. Williams also oversees the real estate division of Williams Investment Company, which currently has undertakings in several locations across the Intermountain West, as well as Hawaii, California, and Baja California, Mexico. Mr. Williams attended the University of Utah, California Institute of the Arts, and La Sorbonne (Paris, France). Mr. Williams has also served as a director, President, CEO, principal financial officer and principal accounting officer of Eastgate Acquisitions Corp., a reporting company, since its inception in September 1999. Mr. Williams resigned as its President and CEO on May 22, 2012. He is also currently a director, President and CEO of Westgate Acquisitions Corp. and, until he resigned in February 2010, he was a director, President and CEO of Greyhound Commissary, Inc., now known as Tanke Biosciences Corp.

(2) Ms. Winn was a director of the Company since September 2013. Ms. Winn is currently employed as Assistant Office Manager at Williams Investment Company, in Salt Lake City, Utah, a financial consulting and corporate services firm involved in facilitating and structuring mergers, acquisitions, business consolidations and financings. Outside of her office duties, Ms. Winn also serves as a member and principal shareholder of Fortune Viniculture, L.L.C., a limited liability company which holds interests in vineyard properties located near Ensenada, Mexico. Additionally, she is the personal Executive Assistant to the Director of Operations of Elite Engineering Solutions, L.L.C., a company offering government compliance services, manufacturing and testing. Ms. Winn resigned from the Company on July 7, 2015.

(3) Ms. Will, for over 20 years has been a private investor; and since co-founding MCB in approximately March 2013, she has been working full-time in various executive capacities with MCB Network, Corp., a Texas corporation. Ms. Will resigned from the Company on February 4, 2016.

(4) Fred Richman, since approximately 2011 has been a private investor; and prior to such time and from 1986, Mr. Richman started and built a dress and sport shirt company for men and boys named Assante Fashions (“Assante”). Assante manufactured shirts in Bulgaria, Cyprus and China, with fabrics from Italy, Switzerland, and Austria, warehoused the shirts in Brooklyn, New York and sold them throughout the United States, under the label “Phatt Farm”, which it licensed from a third party. In approximately 2011, Mr. Richman sold Assante. Mr. Richman resigned from the Company on February 4, 2016.

(5) Mr. Martin was appointed as a Director and President on February 4, 2016. He is a FINRA licensed registered representative and is a seasoned investment banking executive with over 25 years of capital markets experience. He has been the head of capital market teams for a multitude of investment banking and merchant banking operations, raising and structuring capital requirements for dozens of small and middle market companies. Mr. Martin has also been a board member for both public and private companies, advising on both capital raising and business opportunities across a diverse range of industries from biotechnology, metals and mining, healthcare, media and technology. He has been registered with COVA Capital Partners LLC, a FINRA registered broker-dealer, since November 2014, prior to which he had experience working with Ocean Cross Capital Markets LLC (08/2011 - 06/2013), Southridge Investment Group LLC (05/2009 - 08/2011) and TriPoint Global Equities, LLC (06/2007 - 12/2008). Mr. Martin holds FINRA Series 7, 63, and 79 licenses. Mr. Martin graduated from University of Vermont with a degree in Finance in 1990.

(6) Mr. Baum was appointed as a Director, Chief Financial Officer and Chief Operating Officer of the Company on June 13, 2016. He has been a senior executive with proven performance record. He has twenty years of experience in all aspects of Cable Television, Broadband and VOIP operations, including acquisitions, divestitures, acquired capital, strategic business development, budget development & performance to budget. Mr. Baum is also a leader who provides inspiration, clarity, focus and direction to team members, and a creative thinker that relies on proven process to drive results. Mr. Baum is the Founder and CEO of Defensive Drivers Discount since 2011, Founder and Managing Member of Kleen N Green Carwash from June 2010 to August 2011, Founder and CEO of Helicon Cable Holdings LLC from 2005 to 2009, consultant to Cable Marketing Group from 1999 to 2003, Chief Operating Officer other executive positions of Helicon Cable Communications from 1989 to 1999. Mr. Baum attended Boston University School of Engineering from 1980 to 1984.

Family Relationships

Geoff Williams and Rachel Winn, are married.

Other Matters Relating to Our Management

None of our current officers and directors devotes his or her full time to the management of the Company. Since these two individuals have other engagements, each estimates that they will devote between 50% and 75% of their time to the Company and its affairs. We believe that this may be as many as 35 hours per week on the part of each officer and director. Obviously, much of this will depend on how the Company’s future business opportunities develop. Mr. Martin’s efforts will concentrate on business development. Mr. Baum’s efforts will concentrate on the business operations of the Company.

None of our officers and directors has been involved, directly or indirectly, in any bankruptcy or insolvency proceeding of any kind. None is currently involved in any litigation nor has any been involved in any litigation that would have a bearing on any such person's fitness or other ability to act and serve as a director or officer of the Company.

We deny that any person other than our officers or directors or our major shareholder identified above "controls", or has the power to "control," us as contemplated in the "control person" provisions of both state and federal securities laws and as the word "control" is further defined in Rule 405. We may engage consultants or advertising experts in the future but to the extent we do, such persons will likely NOT have an ability to "control" us or our decisions, either directly or indirectly. Further, if we enter into any consulting agreement with any consultant or expert, including an "endorser" of our products, such agreement(s) will provide that to the extent the consultant ever acquires a direct or indirect interest of 5% or more of our issued and outstanding securities, the consultant or endorser will so notify us and otherwise undertake whatever reporting obligation is required of him or her.

Board Meetings and Committees

During the 2015 fiscal year and through the present, nearly all of our Board Meetings were conducted or held in person at our offices where our directors and our majority shareholder work. Some of these Board Meetings have been formalized into written consent minutes and some have simply been advisory in nature, followed up by written consent or other minutes.

As set forth in our Nevada Articles of Incorporation and Bylaws, copies of which are attached to our original Form 10-SB registration statement filed in 2007, all directors hold office until the next annual meeting of stockholders or until their successors have been duly elected and qualified. There are no agreements with respect to the election of directors. Though we have not compensated any director for his or her service on the board of directors or any committee, directors are entitled to be reimbursed for expenses incurred for attendance at meetings of the board of directors and any committee of the board of directors. Due to our current lack of capital resources, our current directors will likely defer his, her or their expenses and any compensation due and owing them, if any, until such time as we can generate retained earnings, if we can, from the sale of our new products or any others we take on. As of the date of this document, our officers and directors have NOT accrued any expenses in their capacities as officers and directors other than their time. As further set forth in our Articles and Bylaws, officers are appointed annually by the Board of Directors and each executive officer serves at the discretion or will of the Board of Directors. We currently have no standing committees and presently have no reason that we are aware of to create any.

Compliance with Section 16(a) of the Securities Exchange Act of 1934

Section 16(a) of the Securities and Exchange Act of 1934 requires officers, directors, and persons who own more than ten percent (10%) of the issuer’s common stock to file initial reports of beneficial ownership and to report changes in such ownership with the Commission and the NASD. These persons are also required to furnish the Company with copies of all Section 16(a) forms they file. These requirements commenced when the Company's Form 10-SB registration statement became effective in 2007. Therefore, as of the date of this Annual Report on Form 10-K, these persons have been subject to the requirements of Section 16(a). Uplift Nutrition has informed these individuals, including our majority shareholder, of their obligations under Section 16(a) and all are otherwise aware of them. Further, we have set up a procedure whereby periodically we will endeavor to (i) notify these persons or other future directors, officers, affiliates or "control persons" of their Section 16(a) obligations; (ii) review the copies of Forms 3, 4, and 5 that these persons will need to file with the Commission; (iii) request written representations from them that no other filings or disclosures were required or necessary; and (iv) make a determination that the pertinent officers, directors and principal shareholders have complied with all applicable Section 16(a) requirements during the fiscal year.

Director and Officer Liability Limitations

Our Articles of Incorporation and Bylaws, both of which were exhibits to our original registration statement on Form 10-SB, limit the personal liability of directors, officers and our shareholders to the full extent allowed by Nevada law. This is a risk factor that an investor or potential investor should consider because it means that a disgruntled or injured investor’s remedies may not be as significant or meaningful as might otherwise be the case in the absence of these statutory and common law protections.

ITEM 11. EXECUTIVE COMPENSATION

31During 2015 and 2014, none of our current officers or directors received any salary or any stock as bonuses, for compensation, or for any other reason. The only officer or director who received compensation of any type or kind over the last two years was our former officer and director, Gary C. Lewis, an individual who had been with us since 2007. In February 2014, he was awarded 200,000 “restricted” shares as compensation for services rendered. Mr. Lewis left us on September 15, 2014 to pursue other opportunities. See the Summary Compensation Table immediately below:

~~ITEM~~SUMMARY COMPENSATION ~~12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT~~ TABLE

AND RELATED STOCKHOLDER MATTERS

											Non-Equity		Non-Qualified
							Stock		Option		Incentive Plan		Deferred		All Other		Total
			Salary		Bonus		Awards		Awards		Compensation		Compensation		Compensation		Earnings
Name	Year		($)		($)		($)		($)		($)		($)		($)		($)
Jessica Stone Rampton		2015	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-
Secretary, Treasurer, CSO and Director thru July 16, 2014		2014	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-

Gary Lewis (1)		2015	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-
President, CEO, CFO and Chairman of the Board thru Sept. 15, 2014		2014	$	-	$	-	$	840	$	-	$	-	$	-	$	-	$	840

Geof Williams		2015	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-
President, CEO, CFO and President from Sept 15, 2014- July 7, 2015		2014	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-

Rachel Winn		2015	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-
Directorafter Sept. 6, 2013 thru July 7, 2015		2014	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-

Sharon Will		2015	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-
President, Secretary, Treasurer and Director from 10 days following the mailing of the Form 14F-1 Information Statement, filed with the SEC on July 7, 2015 until Feb.4, 2016		2014	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-

Sean Martin		2015	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-
Chief Executive Officer, President and Director since Feb. 4, 2016		2014	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-

David Baum		2015	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-
CFO, COO and Director since June 13, 2016		2014	$	-	$	-	$	-	$	-	$	-	$	-	$	-	$	-

34(1) Gary C. Lewis was awarded 200,000 "restricted" shares as compensation for services rendered.

~~ITEM~~We have 13NOT adopted a bonus, stock option, profit sharing, or deferred compensation plan of any sort for the benefit of our employees, officers or directors. This, ~~CERTAIN~~however, ~~RELATIONSHIPS~~does ~~AND~~not ~~RELATED~~mean ~~TRANSACTIONS~~that ~~AND~~we ~~DIRECTOR~~will not do so in the future, given that we are authorized by our Amended Articles to do so without further shareholder approval. See Exhibit 3.2 hereto referenced in Part IV, Item 15 below. Further, we have not entered into an employment agreement of any kind with any of our directors or officers or any other persons and no such agreements are anticipated in the immediate or near future.

~~INDEPENDENCE~~ 18

34Absence of Management Employment and Other Compensation Agreements

~~ITEM~~We do 14not at this time pay any of our officers any salary. We ~~PRINCIPAL~~do ~~ACCOUNTING~~not ~~FEES~~provide ~~AND~~any ~~SERVICES~~other 35 benefits to our officers. We do not have any written agreements with any of our officers and directors.

Each of our officers and directors may engage in other businesses, either individually or through partnerships, limited liability companies, or corporations in which they have an interest, hold an office or serve on boards of directors. All officers and directors have, or will have, other business interests to which they devote their time. Because each of our officers have other engagements, each will probably devote no more than between 50% and 75% of their time to us and our affairs. We believe that this will amount to approximately 25 to 40 hours per week depending upon what is going on with our business and affairs.

Other Key Advisors and Consultants

We have access to several outside professional firms that can counsel us and provide important advice during our development stage. The terms of engagement of these firms will be determined from time to time as their services may be required.

Remuneration and Compensation of Directors

Our current officers and directors do NOT receive any compensation, but may receive compensation for their services to be determined in the future. As stated above, all directors are entitled reimbursement for out-of-pocket expenses incurred by them in behalf, or for the direct benefit, of the Company.

There are no standard arrangements pursuant to which our directors are compensated for any services provided as director, including services for committee participation or for special assignments.

Absence of Key Man Life Insurance

We do not own life insurance covering the death of any officer, director or key employee. Based on our lack of capital and the existence of other, capital-driven priorities, it is highly doubtful that we would spend money towards key man life insurance, even if we had sufficient cash on hand for this purpose, which we currently lack.

Indemnification of Our Officers and Directors

Nevada corporate law in general and applicable provisions of our existing Bylaws authorize us to indemnify any director, officer, agent and/or employee against certain liabilities and to the full extent allowed under Nevada law. Further, we may purchase and maintain insurance on behalf of any such persons whether or not we would have the power to indemnify such person against the liability insured against. Indemnifying and/or insuring officers and directors from the increasing liabilities and risks to which such individuals are exposed as a result of their corporate acts and omissions could result in substantial expenditures by Uplift, while preventing or barring any recovery from such individuals for the possible losses incurred by the Company as a result of their actions. Even assuming that we could afford it, we have no plans to obtain any officer or director (D&O) liability insurance at the present time.

Outstanding Equity Awards at Fiscal Year-End

None during fiscal 2015. However, as stated above, on February 11, 2014, 1 of our directors at the time, namely, Mr. Lewis, was awarded a total of 200,000 “restricted” shares for services rendered as of the date of the award. This increased our issued and outstanding shares by such amount during 2014.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Name of Beneficial Owner	Number of Shares of Common Stock Beneficially* Owned		Percent of Ownership of Common Stock Outstanding

Sean Martin (1)		25,800,000		55.02	%
575 Riverside Ave Suite 102 Westport, Ct 06880

David Baum (2)		5,000,000		10.66	%
575 Riverside Ave Suite 102 Westport, Ct 06880

Directors, officer and 5% or more holders as a group (2 persons only)		30,800,000		65.68	%
5% or Greater Stockholders: Leon Frenkel		10,708,525		22.84	%
Michael Freedman		4,100,000		8.74	%

Beneficial ownership is determined in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC) and generally includes voting or investment power with respect to securities. Shares of common stock issuable upon the exercise of options or warrants currently exercisable, or exercisable or convertible within 60 days, are also deemed outstanding for computing the percentage ownership of the person holding such options or warrants but are not deemed outstanding for computing the percentage ownership of any other person. Nonetheless, the Company has no outstanding stock options, warrants or compensation plans of any kind.

	(1)	SEAN MARTIN, our President and a Director, acquired 13,800,000 of his shares on or about February 4, 2016, upon the automatic conversion of his $41,400 portion of a Company convertible note in the change of control transaction reported on Edgar on Form 8-K, at which time he also became a Director and was appointed our President. Includes 10,000,000 common stock purchase warrants, exercisable over a 5-year period at the exercise price of $.001 per share, awarded on June 3, 2016, and 2,000,000 shares
	(2)	DAVID BAUM, our CFO, COO and Director, received 5,000,000 common stock purchase warrants, exercisable over a 3-year period at the exercise price of $.001 per share, awarded on June 3, 2016

		None of the foregoing persons hold any shares of the Company pursuant to any voting trust or similar agreement.

		As of the date of this report, there are no arrangements or agreements with anyone which may result in a change of control of the Company.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

The Company has conducted transactions with directors and director related entities. These transactions included the following:

On September 6, 2016, the Company entered into a consulting agreement with Sharon Will, a former director of the Company to assist the Company transition to its new operations. The Company agreed to issue this former director 500,000 shares of restricted common stock.

On June 3, 2016, pursuant to an agreement with David Baum, the Company’s current Chief Financial Officer, Chief Operating Officer and a Director, the Company issued warrants to purchase 5,000,000 shares of common stock. The warrants are exercisable for a period of 3 years at a price of $0.001 per share commencing six months after the date of the issue date.

On June 3, 2016, pursuant to an agreement with Sean Martin, the Company issued warrants to purchase 10,000,000 shares of common stock for services rendered. The stock is exercisable for a period of 5 years at a price of $0.001 per share commencing six months after the date of the issue date.

On April 10, 2016, the Company issued a convertible note payable to David Baum for $25,000. The note bore 10% interest per annum and a maturity date of April 10, 2017. The note was convertible at any time into shares of the Company’s common stock at a rate of $0.02 per share. On July 21, 2016, the Company cancelled David Baum’s Note and issued a new revised Note in connection with the Company’s July 1, 2016 offering.

On August 22, 2015, the Company issued a convertible note payable to Sean Martin for $2,000. The note bore 10% interest per annum and a maturity date of August 22, 2016. The note, originally convertible into shares of the Company’s common stock at a rate of $0.02 per share, was amended to change the conversion rate to $0.001 per share. Pursuant to a conversion notice of even date, the Company issued 2,000,000 shares of common stock for the full conversion of this convertible note.

The Company issued 13,800,000 shares of Common Stock to Mr. Sean Martin, the President of the Company and a Director upon the automatic conversion of Mr. Martin’s $41,400 portion of a convertible promissory note of the Company that he purchased from Edward F. Cowle, pursuant to a Note Purchase and Conversion Agreement dated as of June 4, 2015 by and among, among others, Mr. Cowle and five (5) purchasers, including Mr. Martin who was then employed by Cova Capital Partners LLC (“CCP”). CCP was the broker/dealer for a private placement by MCB Network, Corp. (“MCB”) in the Company pursuant to which MCB (i) raised, among other additional funds, the funds used by MCB to purchase 9,476,150 shares of Common Stock of the Company from Mr. Cowle, H. Deworth Williams and Geoff Williams (the “Sellers”) pursuant to a Stock Purchase Agreement dated as of June 8, 2015 (the “SPA”) and (ii) paid to CCP $41,500 in commissions and issued to it warrants to purchase 33,200 shares of MCB’s Common Stock in connection with such private placement. Mr. Martin is not currently employed by CCP, does not have any ownership stake in CCP and does not have any vote on CCP matters.

Stock Purchase Agreement

On June 8, 2015, pursuant to a Stock Purchase Agreement dated as of June 4, 2015 (the “SPA”) by and among, among others, Edward F. Cowle, H. Deworth Williams (“HD Williams”) and Geoff Williams (each a “Seller,” and, collectively, the “Sellers”), and MCB Network, Corp., a Texas corporation (“MCB”), the Sellers sold (the “Share Block Acquisition”) to MCB, 9,476,150 shares (the “Shares”) of restricted Common Stock, owned by the Sellers for an aggregate purchase price of $135,509. H.D. Williams was a stockholder, affiliate and control person of the Company at the time and is currently owner of record and beneficiary of 2,000,000 shares of Common Stock and will remain an affiliate of the Company for a period of 90 days from the June 8, 2015 closing date of the Transaction, (as defined below), and Geoff Williams, his son, was and will remain until the Schedule 14 Information Statement Effective Date, the Chairman of the Board, Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary of the Company, and, on the date 90 days after the Schedule 14 Information Statement Effective, Geoff Williams was no longer an affiliate of the Company.

Cowle Note Purchase and Conversion Agreements

On June 8, 2015, pursuant to a Note Purchase and Conversion Agreement dated as of June 4, 2015 (the “Cowle NPA”), by and among, among others, Mr. Cowle and five (5) purchasers (each a “Cowle Note Purchaser,” and collectively the “Cowle Note Purchasers”), each Cowle Note Purchaser purchased (the “Cowle Note Acquisition”), a portion of the $67,027 outstanding amount of the convertible promissory note of the Company owned by Mr. Cowle the (the “Cowle Note”). Simultaneously with the closing of the Share Block Acquisition, the Williams Note Acquisition (as defined below), and the Cowle Note Acquisition (collectively the “Transaction”), each portion of the Cowle Note purchased by a Cowle Note Purchaser automatically converted, pursuant to the terms of the Cowle NPA, into restricted shares of Common Stock, which in the aggregate resulted in the issuance to the Cowle Note Purchasers of 23,000,000 restricted shares of Common Stock and, thereafter, the Cowle Note was cancelled.

H.D. Williams Note Purchase and Conversion Agreement

On June 8, 2015, pursuant to a Note Purchase and Conversion Agreement dated as of June 4, 2015 by and among, among others, HD Williams and the eleven (11) purchasers (each an “HD William Note Purchaser,” and collectively, the “Williams Note Purchasers,” and together with MCB, as the purchaser of the 9,476,150 Shares pursuant to the SPA, and the Cowle Note Purchasers, collectively, the “Purchasers”), named therein (the “Williams NPA,” and together with the Cowle NPA and the SPA, collectively, the “Transaction Agreements”), each Williams Note Purchaser purchased a portion of the $51,061 outstanding amount of the convertible promissory note of the Company owned by HD Williams (the “Williams Note”), for an aggregate purchase price of $51,061 (the “Williams Note Acquisitions”). Simultaneously with the closing of the Transaction, each portion of the Williams Note purchased by a Williams Note Purchaser automatically converted, pursuant to the terms of the Williams SPA, into restricted shares of Common Stock, which in the aggregate resulted in the issuance to the Williams Note Purchasers of 10,000,000 shares of restricted Common Stock, and, thereafter, the Williams Note was cancelled.

Immediately prior to the closing of the Transaction, the Company had issued and outstanding 13,892,597 shares of Common Stock; and immediately following the closing of the Transaction the Company had issued and outstanding 46,892,597 shares of Common Stock, which increase resulted from the issuance of an aggregate of 33,000,000 restricted shares issued by the Company to the Cowle Note Purchasers and the Williams Note Purchasers upon the automatic conversion of the Cowle Note and the Williams Note on the closing date of the Transaction pursuant to the Cowle NPA and the Williams NPA, respectively.

Irrevocable Proxy and Lock-Up Agreements

As a condition to the closing of the Transaction, each Purchaser (including MCB) executed in favor of Sharon Will, who may be deemed a control person of MCB and following the closing of the Transaction, the Company, an Irrevocable Proxy and Lock-Up Agreement (each an “Irrevocable Proxy,” and, collectively, the “Irrevocable Proxies”), pursuant to which each Purchaser (i) provided Ms. Will the right to vote, and (ii) agreed not to sell, transfer and/or otherwise dispose of, any of such Purchaser’s shares of Common Stock until the date three (3) business days following the date the Company files with the Securities and Exchange Commission (the “SEC”), a Current Report on Form 8-K with Form 10 type information disclosing an acquisition by the Company of a business.

Anticipated Change of Board and Directors

Pursuant to the terms of the Transaction Agreements, on the Schedule 14 Information Statement Effective Date, (i) the previously provided resignations of the two (2) current officers and directors of the Company (Geoff Williams and Rachel Winn) as officers and/or directors of the Company, and (ii) the prior “subject to” appointments by the Board of Ms. Will and Fred Richman, as the then sole directors of the Company, became effective automatically resulting in Ms. Will and Mr. Richman becoming the then sole directors of the Company and Ms. Will and Mr. Richman and Ms. Will was appointed as the president, secretary and treasurer of the Company.

Payments to Third Party

Pursuant to the SPA, the Sellers, at the closing of the Transaction (i) paid $30,000, and (ii) sold $1,403.66 of the Cowle Note which converted into 1,300,000 restricted shares of Common Stock, to a third party retained by the Sellers in connection with the Transaction.

The foregoing descriptions of the Transaction, the SPA, the Cowle NPA and the Williams NPA and the transactions described therein, are qualified in their entirety by reference to the SPA, the Cowle NPA and the Williams NPA, respectively, each of which is attached as an exhibit to the Company’s Current Report on Form 8-K dated June 8, 2015, and filed with the Securities and Exchange Commission (the “SEC”), on June 12, 2015.

As a result of the (i) issuance of the 33,000,000 shares of restricted Common Stock to the Cowle Note Purchasers (23,000,000 restricted shares) and the Williams Note Purchasers (10,000,000 restricted shares), (ii) the execution by all of the Purchasers, including MCB, of an Irrevocable Proxy in favor of Ms. Will and (iii) the sale of the 9,476,150 shares from the 3 Sellers to MCB pursuant to the SPA, voting control of the Company shifted from the Sellers to Ms. Will.

(a) Prior to the Closing of the Transaction

Immediately prior to the closing of the Transaction, the Company had 13,892,597 shares of Common Stock issued and outstanding; and immediately following the closing of the Transaction, the Company had 46,892,597 shares of Common Stock issued and outstanding, which 33,000,000 share increase resulted from the issuance, on the closing date of the Transaction pursuant to the Transaction Agreements, of the 33,000,000 shares of the Company’s restricted Common Stock to the Cowle Note Purchasers and the Williams Note Purchasers as a result of the automatic conversion of the Cowle Note (into 23,000,000 restricted shares) pursuant to the Cowle NPA and the Williams Note (into 10,000,000 restricted shares) pursuant to the Williams NPA.

The following table and footnotes thereto sets forth the number of shares of Common Stock beneficially owned immediately prior to the closing of the Transaction by (i) each director and named executive officer of the Company, (ii) each person known by the Company to be the beneficial owner of more than 5% of its issued and outstanding shares of Common Stock, and (iii) all named executive officers and directors of the Company as a group. In calculating any percentage in the following table of Common Stock beneficially owned by one or more persons named therein, the following table assumes 13,892,597 shares of Common Stock issued and outstanding immediately prior to the closing of the Transaction. Except for the granting by each Purchaser pursuant to the Transaction Documents of an Irrevocable Proxy in favor of Ms. Will as described elsewhere in this Information Statement and/or unless further otherwise indicated in the following table, the footnotes thereto and/or elsewhere in this Information Statement, the persons and entities named in the following table have sole voting and sole investment power with respect to the shares set forth opposite the person’s name, subject to community property laws, where applicable. The address of each stockholder listed in the following table is: c/o Uplift Nutrition, Inc., 2681 East Parleys Way, Suite 204, Salt Lake City, Utah 84108.

Name	Title		Number of Shares of Common Stock Beneficially Owned Immediately Prior to the Closing of the Transaction			Percentage of Common Stock Beneficially owned Immediately Prior to the Closing of the Transaction ^{[1], [2]}
DIRECTORS AND EXECUTIVES OFFICERS
Geoff Williams		Chief Executive Officer, Chief Financial Officer, President, Secretary, Treasurer and Chairman of the Board		441,600			3.2	%
Rachel Winn		Director		-0-			-0-
ALL OFFICERS AND DIRECTORS AS A GROUP (2 persons)		___		441,600			3.2	%
5% OR GREATER STOCKHOLDERS
H. Deworth Williams				10,401,550	^[2]		74.87	%

^[1]

Under Rule 13d-3 of the Exchange Act, a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has or shares: (i) voting power, which includes the power to vote, or to direct the voting of shares; and (ii) investment power, which includes the power to dispose or direct the disposition of shares. Certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares outstanding is deemed to include the amount of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the above table does not necessarily reflect the person’s actual ownership or voting power with respect to the number of shares of Common Stock actually outstanding on the date of this Information Statement.

^[2]

Excludes all 33,000,000 shares issuable upon conversion of the Williams Note and the Cowle Note on the closing date of the Transaction as no conversion terms had previously been agreed upon between the Company and H.D. Williams as to the Williams Note; and the Company and Mr. Cowle as to the Cowle Note, as required pursuant to the Williams Note and the Cowle Note prior to any conversions.

(b)

Following the Closing of the Transaction

The following table and footnotes thereto sets forth information regarding the number of shares of Common Stock beneficially owned immediately following the closing of the Transaction by (i) each director and named executive officer of the Company, (ii) each person known by the Company to be the beneficial owner of 5% or more of its issued and outstanding shares of Common Stock, and (iii) all named executive officers and directors of the Company as a group. In calculating any percentage in the following table of Common Stock beneficially owned by one or more persons named therein, the following table assumes 46,892,597 shares of Common Stock issued and outstanding immediately following the closing of the Transaction. Except for the Irrevocable Proxies granted by each Purchaser to Ms. Will with regard to the voting right of all 44,476,150 shares issued and/or sold to the Purchasers in the Transaction pursuant to the Transaction Agreements and/or unless otherwise further indicated in the following table, the footnotes thereto and/or elsewhere in this Information Statement, the persons and entities named in the following table have sole voting and sole investment power with respect to the shares set forth opposite the stockholder’s name, subject to community property laws, where applicable. Unless as otherwise indicated in the following table and/or the footnotes thereto, the address of each person and/or entity named in the following table is: c/o MCB Networks, Corp., 1201 West 5^th Street (M-160), Los Angeles, California 90017.

Name	Title	Number of Shares of Common Stock Beneficially Owned Immediately Following the Closing of the Transaction		Percentage of Common Stock Beneficially Owned Immediately Following the Closing of the Transaction^[1]
CURRENT DIRECTORS AND EXECUTIVE OFFICERS AND TO BE APPOINTED DIRECTORS AND EXECUTIVE OFFICERS
Geoff Williams^[2]	Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and Director		-		-
Rachel Winn^[2]	Director		-		-
Sharon D. Will^[3]	Director, President, Treasurer and Secretary		42,476,150		90.58	%
Fred Richman^[4]	Director		2,000,000		4.27	%
ALL CURRENT AND TO BE APPOINTED EXECUTIVE OFFICERS AND DIRECTORS AS A GROUP (4 persons)	___		44,476,150		94.85	%
5% OR GREATER STOCKHOLDERS
MCB Network, Corp^[5]	___		42,476,150		90.58	%
Leon Frenkel^[6]	___		5,000,000		10.66	%
Sean C. Martin^[7]	___		13,800,000		29.43	%
Michael Freedman^[8]	___		4,100,000		8.74	%

^[1]	Under Rule 13d-3 of the Exchange Act, a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has or shares: (i) voting power, which includes the power to vote, or to direct the voting of shares; and (ii) investment power, which includes the power to dispose or direct the disposition of shares. Certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares outstanding is deemed to include the amount of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the above table does not necessarily reflect the person’s actual ownership or voting power with respect to the number of shares of Common Stock actually outstanding on the date of this Information Statement.

^[2]	Upon the Schedule 14 Information Statement Effective Date, such person pursuant to such person’s previously provided resignation, automatically will be deemed to have resigned from all positions with the Company including as a director.

^[3]	Consists of (i) 9,476,150 Shares purchased by MCB from the Sellers pursuant to the SPA, and (ii) 33,000,000 shares in the aggregate issued to the Cowle Note Purchasers and the Williams Note Purchasers upon the automatic conversion of the Cowle Note and Williams Note pursuant to the Cowle NPA and the Williams NPA on the closing of the Transaction, of which all Purchasers of such 42,476,150 shares granted to Ms. Will an Irrevocable Proxy to vote such shares for the time period set forth in the Irrevocable Proxy. Ms. Will disclaims beneficial ownership of all such 42,476,150 shares. Ms. Will may have been deemed a control person of MCB; and of the Registrant. On the Schedule 14 Information Statement Effective Date, Ms. Will became a director and the president, secretary and treasurer of the Company.

^[4]	Consists of (i) 9,476,150 Shares purchased by MCB from the Sellers pursuant to the SPA, and (ii) 33,000,000 shares in the aggregate issued to the Cowle Note Purchasers and the Williams Note Purchasers upon the automatic conversion of the Cowle Note and Williams Note pursuant to the Cowle NPA and the Williams NPA on the closing of the Transaction. Mr. Richman disclaims beneficial ownership of all such 42,476,150 shares, except 2,000,000 shares of Common Stock issued to Mr. Richman by the Company upon the automatic conversion of Mr. Richman’s $10,600 portion of the Williams Note pursuant to the Williams NPA upon the closing of the Transaction. Mr. Richman granted to Ms. Will an Irrevocable Proxy on all such 2,000,000 shares. Mr. Richman is a Director of MCB, and, as a result, may have been deemed a control person of MCB; and upon the Schedule 14 Information Statement Effective Date, Mr. Richman became a Director of the Company, and as a result, at such time, may have been deemed a control person of the Company.

^[5]	Consists of (i) the 9,476,150 Shares purchased by MCB from the Sellers pursuant to the SPA, and (ii) the 33,000,000 shares issued to the Cowle Note Purchasers and the Williams Note Purchasers upon the automatic conversion of the Cowle Note and Williams Note upon the closing of the Transaction pursuant to the Cowle NPA and the Williams NPA. All Purchasers (including MCB), granted to Ms. Will an Irrevocable Proxy on all such 42,476,150 shares. Ms. Will may have been deemed a control person of the Company and MCB. Other than the 9,476,150 shares, MCB disclaimed beneficial ownership of any other securities of the Company.

^[6]	The Company issued such 5,000,000 shares to Mr. Frenkel upon the automatic conversion of Mr. Frenkel’s $15,000 portion of the Cowle Note on the closing of the Transaction pursuant to the Cowle NPA. Pursuant to an Irrevocable Proxy, Mr. Frenkel granted Ms. Will voting rights to all such 5,000,000 shares. Mr. Frenkel also purchased and owns 250,000 shares of common stock and common stock purchase warrants to purchase 125,000 shares of common stock of MCB. Based upon information provided by such person, the address of such person is 1600 Flat Rock Road, Penn Valley, PA 19072.

^[7]	The Company issued such 13,800,000 shares to Mr. Martin upon the automatic conversion of Mr. Martin’s $41,400 portion of the Cowle Note on the closing date of the Transaction pursuant to the Cowle NPA. Pursuant to an Irrevocable Proxy, Mr. Martin granted Ms. Will voting rights to all such 13,800,000 shares. Based upon publicly available information, Mr. Martin is licensed by FINRA as a Series 7 general securities representative and a Series 24 general securities representative and is currently employed by Cova Capital Partners LLC (“*CCP*”), a FINRA member broker/dealer as a general securities principal. CCP is the broker/dealer for MCB’s private placement pursuant to which MCB raised, among other additional funds, the funds used by MCB to purchase the 9,476,150 Shares from the 3 Sellers pursuant to the SPA and paid to CCP through the date hereof, $41,500 in commissions and issued to it warrants to purchase 33,200 shares of MCB common stock in connection with such MCB private placement. Based upon information provided by such person, the address of such person is 61 Larbert Road, South Port, Connecticut 06890.

^[8]	The Company issued such 4,100,000 restricted shares to Mr. Freedman upon the automatic conversion of Mr. Freedman’s (i) $5,623 portion of the Cowle Note (1,700,000 shares), and (ii) $11,311 portion of the Williams Note (2,400,000 shares) upon the closing of the Transaction pursuant to the Cowle NPA and the Williams NPA, respectively. Pursuant to Irrevocable Proxies, Mr. Freedman granted Ms. Will voting rights to all such 4,100,000 shares. Based upon information provided by such person, the address of such person is 394 White Birch Lane, Jericho, New York 11753.

While voting control of the Company changed on the closing of the Transaction by virtue of (i) the sale to MCB by the Sellers of the 9,476,150 Shares pursuant to the SPA, (ii) the issuance of the 33,000,000 shares pursuant to the Transaction to the Cowle Note Purchasers and the Williams Note Purchasers, and (iii) the granting by each Purchaser of an Irrevocable Proxy in favor of Ms. Will with respect to the 42,476,150 shares received by the Purchasers in the Transaction, there was not any change in the officers and/or the Board until the Schedule 14F Information Statement Effective Date. Accordingly, until the Schedule 14F Information Statement Effective Date, Geoff Williams continued as Chairman of the Board, CEO, President, CFO, Secretary and Treasurer and Ms. Winn continued as a Director of the Company; and following such date, such persons automatically were deemed to have resigned all such positions with the Company and Ms. Will and Mr. Richman became the sole directors of the Board and Ms. Will also became the President, Secretary and Treasurer of the Company.

Like any other corporate officer or director, each director and officer is subject to the doctrine of usurpation of corporate opportunities only insofar as it applies to business transactions in which we have indicated an interest, either through our proposed business plan or by way of an express statement of interest contained in our minutes. If any director or officer is presented in the future with a business opportunity that may conflict with business interests identified by us, such an opportunity must be promptly disclosed to the Board of Directors and otherwise made known to us. In the event that the Board rejects an opportunity so presented, and only in that event, can one of our officers or directors avail him or herself of such opportunity. In spite of these eventualities, every effort will be made to resolve any conflicts that may arise in favor of us and our stockholders. There can be no assurance, however, that these efforts will be successful. As a Nevada corporation, we are obligated, among other things, to comply with the provisions of Nevada law, NRS 78.140 titled "Restrictions on transactions involving interested directors or officers; compensation of directors." We are not aware of any such conflicts of interest at this time and to be more specific, we are not aware of any opportunity whatsoever that we would reject and that an officer or director or even our majority stockholder would likely engage in or take advantage of.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

The aggregate fees included in the Audit category are fees billed for the year-end audit of our annual financial statements and review of financial statements and statutory and regulatory filings or engagements. The aggregate fees included in each of the other categories are fees billed in the calendar years indicated.

Fee Category	2015		2014
Audit Fees	$	9,500	$	12,000
Audit-related Fees		-		-
Tax Fees		-		-
All Other Fees		-		-
Total Fees	$	9,500	$	12,000

Audit fees for the years ended December 31, 2015 and 2014 were for professional services rendered for the audits of our financial statements, quarterly review of the financial statements included in the Quarterly Reports on Form 10-Q, consents and other assistance required to complete the year- end audit of our financial statements.

Audit-Related Fees as of the years ended December 31, 2015 and 2014 were for the assurance and related services reasonably related to the performance of the audit or review of financial statements and not reported under the caption Audit Fees.

Tax Fees as of the years ended December 31, 2015 and 2014 were for professional services related to tax compliance, tax authority audit support and tax planning.

There were no fees that were classified as All Other Fees as of the years ended December 31, 2015 and 2014.

As we do not have a formal audit committee, the services described above were not approved by the audit committee under the de minimus exception provided by Rule 2-01(c) (7)(i)(C) under Regulation S-X. Further, as we do not have a formal audit committee, we do not have, at this time, audit committee pre- approval policies and procedures.

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES .

36The following Exhibits are filed as a part of this Annual Report on Form 10-K:

Exhibit Number		Description
31.1		Sarbanes-Oxley Section 302 Certification
31.2		Sarbanes-Oxley Section 302 Certification
32.1		Sarbanes-Oxley Section 906 Certification
32.2		Sarbanes-Oxley Section 906 Certification

~~PART~~* Summaries Iof all exhibits contained within this Annual Report are modified in their entirety by reference to the foregoing Exhibits.

~~ITEM~~The following 1.Exhibits ~~BUSINESS.~~are incorporated by reference as a part of this Annual Report on Form 10-K:

We are a start-up, internet-based eCommerce company that has historically offered and sold a new natural energy and health drink called Active UpLift® in two different flavors and also, an energy spray called All-Day Energy Spray®3. We1 Articles ~~discontinued marketing those two products in 2013 for want~~ of ~~sufficient advertising capital. We have also lacked the advertising capital to introduce another new and innovative energy drink~~Incorporation, EpiGaia™, to the public and market it in a significant or meaningful way. The introduction of that product is thus “on hold.” Having said this, starting in the end of 2012, we began marketing on our updated website, www.upliftnutritioninc.com, a new product called “Tonify,” which iswere afiled ~~raspberry~~as ~~keytone~~an ~~chewing~~exhibit ~~gum designed~~ to ~~burn~~our ~~fat. We~~November ~~also began marketing a product called “X-Mint~~2,” ~~a male enhancement chewing gum. During the fiscal year~~2007, ~~and~~Form ~~because sale of Tonify and X~~10-~~Mint~~SB ~~had~~registration not been as we had hoped, we began marketing a new product called “Gray-to-Great,” a product designed to put gray hair back to its natural color. Starting in October, we also began marketing a product called Mitigator®. In the fourth quarter, we had approximately $8,000 in sales.statement

~~During~~3.2 Amendments ~~2014,~~to ~~we no longer offered~~ our ~~former~~Articles ~~principal~~of ~~products~~Incorporation ~~Active~~filed ~~UpLift®~~with orand ~~All-Day~~stamped ~~Energy~~by ~~Spray®~~the ~~for~~State ~~sale~~of Nevada on aNovember ~~retail basis or through our primary website~~21, ~~www.upliftnutritioninc.com. What~~2011 weand the ~~have~~corollary inNevada ~~inventory~~Certificate ~~essentially~~of ~~expired and~~Amendment, atcopies ~~this~~of ~~time,~~which wewere ~~have~~filed nowith ~~plans~~our to2012 ~~mix~~Annual ~~more~~Report ofon ~~either~~Form ~~product.~~ 10-K

Of3.3 Bylaws, ~~the~~which ~~three websites that~~ were ~~active~~filed atas ~~the~~an ~~end~~exhibit ofto our ~~previous~~November ~~year~~2, ~~only~~2007, ~~one~~Form ~~is currently active. The two that have been de~~10-~~activated~~SB orregistration shut down are www.upliftenergy.com and www.alldayenergyspray. The upliftnutritioninc.com website was rebuilt. At one time, we had a website www.EpiGaia.com but because we have held off in marketing that particular product at the present time, that website is no longer functional.statement

Approximately 2 years ago, we completely revamped and updated our principal website, www.upliftnutritioninc.com. It now solicits the purchase of the two new products we have been distributing mentioned above called Tonify and X-Mint. In this regard, in November 2012 we entered into an exclusive representation letter agreement with Tonify and X-Mint’s manufacturer, Healthy Life Nutraceutics, Inc. (“Healthy Life”), out of Deerfield, Illinois, to “distribute” these 2 products in a specific market segment that we had previously established through our attempts to market our other, earlier products. As a distributor, we maintain a customer base that has subscribed to our promotions and advertising. This market does NOT include seller channels or portals such as Ebay, Amazon, Google Shopping or similar search engine optimization channels, nor online stores such as Drugstore.com, Vitacoast.com or similar channels. This letter agreement may be terminated by Healthy Life on 60 days’ written notice, with or without cause. Healthy Life determines the prices at which we are able to offer and sell their products. 27

While we have made several significant contacts in the retail food business over the last several years, we were unable to seriously launch Active UpLift ® or All-Day Energy Spray® in any national convenience or other large food chain stores for want of advertising capital. This is the biggest problem we have faced during the last three fiscal years and the biggest problem we currently face. SIGNATURES

AsIn accordance ~~disclosed~~with inthe ~~earlier~~provisions ~~Annual~~of ~~Reports~~the onSecurities ~~Form~~and ~~10-K,~~Exchange ~~our~~Act ~~new~~of ~~green~~1934 ~~tea~~and ~~drink~~the isrules ~~fully~~and ~~developed~~regulations ~~but~~promulgated isthereunder, UPLIFT ~~also~~NUTRITION, ~~not currently being marketed~~INC. ~~Our other new “super juice” drink~~, ~~EpiGaia™~~has ~~mentioned~~duly ~~above~~caused isthis ~~also~~Annual ~~not~~Report ~~being~~on ~~marketed~~Form at10-K ~~present, also~~ for ~~want~~its offiscal ~~sufficient~~year ~~advertising~~ended ~~capital. We~~December ~~remain ready and willing~~31, ~~however~~2015, to ~~commence~~be ~~substantial~~signed on ~~marketing~~its ~~efforts~~behalf ofby ~~these products t if we have~~ the ~~resources~~undersigned, tothereunto doduly soauthorized.

Unless and until we can generate substantial advertising capital in some fashion, our ability to remain in business in our current form through the next year or two may be in doubt even in light of the fact that we have a new majority shareholder who is willing to finance us in maintaining our good standing status with the SEC and in our various Edgar filing obligations.

		UPLIFT NUTRITION, INC., Issuer

Date:	January 19, 2017	By:	/s/ Sean Martin
			Sean Martin
			President, Chief Executive Officer and Director

Date:	January 19, 2017	By:	/s/ David Baum
			David Baum
			Chief Financial Officer and Chief Operating Officer and Director

During 2014, we took on two additional products that we are currently marketing as described in the subheading Principal Products or Services Now Offered and Their Markets described below. As stated above, these new products are “Gray to Great” and Mitigator®.28

Current Status of the Company

We are not involved in any joint venture with any other party. Along with our current distributer agreement with Healthy Life (referenced above), in December of 2014, we entered into distribution agreement with Shanna Wrapp & Associates. This was to set up retail outlets and otherwise provide her with particular outlets on a wholesale basis. We are always continuing to look at whether we can enter into any advertising, marketing and vendor distribution agreements with various retailers and on what terms. This is something that we are doing on an on-going basis in the ordinary course of our business.

As set forth in our balance sheet in Part F/S below, as of December 31, 2014, we had $10,499 in cash and approximately $355 worth of product inventory. All previously held inventory has been written off due to obsolescence and also, due to our current and recent efforts to focus on the sale of Tonify, X-Mint, Gray-to-Great, and Mitigator®, all as described in more detail below.

We maintain executive offices or facilities at the offices of our majority shareholder located at 2681 East Parleys Way, Suite 204

Utah 84109. We do not pay rent for these office facilities because their use is only nominal.

We do not maintain a products liability insurance policy because we are relying on the product manufacturers’ policies in that regard.

For and as of our year end, December 31, 2014, we had revenues of $8,806. We had zero dollars in deferred revenue representing sales for which the right of return has not been determined or expired. For and as of our fiscal year end, we did not have any retail grocery store chain sales with Ralphs, Albertsons, and Harmons as we have had in past years because we have discontinued the sale of those products using grocery store outlets. We believe that our retail sales during all of 2014 were not as substantial as we would have wanted simply because, as disclosed elsewhere herein, we lack sufficient advertising capital. Also, control of the Company changed in September 2013, just over a year ago. Current management cannot predict whether we will ever be profitable even though there is admittedly a large market for our total of four (4) new products we are distributing or retailing through our single website.

As of December 31, 2014, we had a net working capital deficiency of $106,293. At the same time, we currently have a financial commitment for day-to-day operations through our majority shareholder, H. Deworth Williams. This commitment does NOT include providing the advertising capital necessary to do pay-per-click or other advertising on websites such as Google and Yahoo! Such a commitment would involve several thousands of dollars. Mr. Williams’ commitment is to provide us with sufficient working capital over at least the next year as necessary to continue to be “current” in our reporting obligations with the U.S. Securities and Exchange Commission (SEC). We consider his generous commitment to keep us current in our reporting obligations for at least the next year or two a legal obligation, even though we have no written agreement with him to this effect. We do not have a written agreement with Mr. Williams to this effect because we believe that he has enough shares at this time and if we were to do so, such an agreement might require giving him additional shares in the event that we default on our obligation to him, something that neither of us believes is necessary to provide for at this time. If Mr. Williams decides not to advance us additional funds and yet our business prospects look positive or favorable, we may consider raising money by selling our common stock on a private placement or other basis. Additional thought and consideration has been given to this prospect but we have nothing significant or meaningful to report in this regard. If such occurs, existing shareholders would likely be substantially diluted.

Even though we have four (4) new products we are distributing and retailing through our website and for which we believe there is an enormous market, because of the start-up nature of our offering these particular products, there exists substantial doubt regarding our ability to continue as a going concern. See Part II, Item 8 below. No assurance can be given that we will become successful or that we will generate enough capital from sales of these four new products to continue to finance necessary advertising campaigns, let alone undertake new advertising campaigns such as advertising in food magazines or in a variety of health food and nutrition venues. In this regard, reference is made to our "Plan of Operation" section below.

Our current stock transfer agent is Fidelity Transfer Company located at 8915 South 700 East, Suite 102, Sandy, Utah 84070, phone number 801-562-1300; fax number 801-233-0589.

As of the date of this document, we have approximately 1,244 shareholders of record. Fidelity Transfer Company has been our transfer agent since our initial public offering back in the 1950’s. We have but one class of stock issued and outstanding, that being common capital voting stock having a par value of $0.001 per share. Effective in December 2011, FINRA approved a 1 for 20 reverse split of common capital shares of which 100,000,000 common shares are authorized. A month prior thereto, effective November 21, 2011, the Secretary of State of the State of Nevada accepted an amendment to our Articles authorizing the issuance of as many as 10 million preferred shares, having a par value of $0.001 per share, the same as our common stock. No such shares have been issued nor are any currently outstanding. The rights and preferences relating to such preferred shares are subject to the discretion of our Board of Directors and the parameters are set forth in a Certificate of Designation filed with the State of Nevada on November 21, 2011. This was disclosed in a 14C Information Statement we filed on the SEC’s Edgar database in November 2011 and which was mailed out to our stockholders at that time.

Of the 13,892,597 common shares issued and outstanding as of December 31, 2014, our officers and directors and majority shareholder own and hold or control, directly and indirectly, a total of 10,843,150 shares. This figure represents 78% percent of our total number of issued common shares. See Item 12 of Part III below.

Principal Products or Services Now Offered and Their Markets

Tonify and X-Mint

Approximately 2 years ago, we began marketing on our updated website, www.upliftnutritioninc.com, a new product called “Tonify,” which is a raspberry keytone chewing gum designed to burn fat. We also began marketing a second product made by the same manufacturer called “X-Mint,” a male enhancement chewing gum.

We believe that the overall nutritional market has exploded in size as the “yuppie” generation (the 50’s and 60’s) have begun to age into their 50’s. This generation of Americans has been and are still today, very resistant to normal aging. Billions of dollars have been spent on nutrient and age delaying products that will help keep the population looking and, especially feeling, young and being as fit as possible. Thusly, the overweight and male enhancement markets have grown substantially in size over recent years as well. Billions of retail dollars are now being spent annually by both males and females on the newest and most advanced youth enhancement products available. We feel that Tonify and X-Mint are just two products that fill this niche.

Our previous principal business plan up to and through the end of the last two years had been to promote, market and sell our energy spray All Day Energy Spray® through the active websites we were at that time operating but, at the end of that fiscal year, management modified our marketing strategy, rebuilt our www.upliftnutritioninc.com website, and entered into a marketing agreement to sell the two new products called “Tonify” and “X-Mint” through our updated website. Because of our change in the products we were featuring in about 2 years ago, we shut down our two other major websites, namely, www.alldayenergyspray.com and upliftenergy.com so we could concentrate all of our marketing and sales efforts on our one principal website.

As a result of winding down our marketing efforts with respect to Active UpLift® and All Day Energy Spray®, we have had less than anticipated sales and gross revenue on these two new products to date. Part of this is due to the fact that, as stated in our second quarter report on Form 10-Q, the manufacturer of Tonify and X-Mint, during 2014, temporarily suspended manufacturing both products to do re-formulation so the products would better hold their flavor longer and not have a particular aftertaste that some users were experiencing. Because of this situation during the 2014 calendar year, we were somewhat hampered in our ability to maintain an inventory at the time. In addition, because of concerns that we might not be able to acquire sufficient Tonify and X-Mint in inventory in the future, we took on two additional products during 2014. A description of these two new products follows. Based on our current situation, it appears that we will be phasing our sales efforts of Tonify and X-Mint and concentrating more on Gray-to-Great and Mitigator®, perhaps even taking on additional products.

Gray to Great

As disclosed in previous EDGAR filings, on March 21, 2014, we entered into a non-exclusive dealer agreement with Nylasan, LLC (“Nylassan”), a Utah based re-seller of neutraceuticals, to market their product “Gray-to-Great.” Gray-to-Great is an all-natural anti-graying formula that will restore graying hair on both males and females to its natural color. It is made from the following basic ingredients: vitamin B6, folic acid, biotin, pantothenic acid, zinc, catalase, horse tail, saw palmetto, plant sterols, nettle root extract, chlorophyll, fo ti powder, barley grass juice powder and other ingredients. The product has been used by individuals who have reported back to the manufacturer that, within 60 to 90 days, they have seen a distinct reduction in the gray color of their hair, back to a more natural color.

Nylassan is not the actual manufacturer of Gray-to-Great. Instead, it buys product from a “white label” manufacturer known as Private Label Neutraceuticals, LLC (“Private Label”), located in Norcross, Georgia, whose website is www.privatelabelnutra.com . Private Label manufactures a variety of health food products and sells them on a “white label” basis to various distributors such as Nylassan. Distributors can then re-label the product as they wish. Gray-to-Great was developed and is manufactured by Private Label in pill form and should be taken at least twice daily up to as many as three doses per day. One positive aspect of our arrangement with Nylassan, our lead distributor, is that it is less than 50 miles from our location. For this reason, if necessary, we can easily obtain more product to distribute as needed. The close proximity of Nylassan also allows us take a closer look at other Nylasan products that we might wish to add to our marketing program in the future, decisions on which have not as yet been made. Our non-exclusive agreement with Nylassan allows us the ability to add new products to our inventory and the time needed to decide whether we want to take on new products offered by it.

If a person goes to www.privatelabelnutra.com and types the word “gray” in the search engine, one can pull up testimonials related to Private Label’s “anti-graying formula.”

The product sells at the retail level at $9.95 per 60 pills, which would normally last for up to 1 month. The suggested retail price is very competitive with topical anti-gray products that are currently sold on the market today. Unlike some topical anti-gray products, this product is all natural, and taken into the body to naturally change the hair color.

Since Gray-to-Great is an ingested product, we have been assured from Nylasan that it has products liability insurance on the product covering any liability to Nylasan distributors, including a commitment to defend litigation. We are also informed that Private Label also has extensive products liability insurance.

We are excited to have been able to add this new product to our product sales line during 2014. See our website, www.upliftnutritioninc.com. We may also consider selling other products on our website currently offered by Nylassan, our master distributor mentioned above, all as per our current distributorship agreement with it.

Mitigator®

After the end of the fourth quarter, our management entered into an agreement with a related party to take on the sale of a new anti-itch, sting and bite cream product designed to resolve insect sting and bite trauma known as Mitigator ®. See www.mitigator.net. Mitigator® works by:

· Removing the top layer of dead skin

· Opening and softening the skin’s pores

· Drawing the toxins from the open pores

· Creating circulation, thereby forcing toxins through the open pores to the surface

· Neutralizing the toxins and cleansing the affected area

· Satisfying the impulse to scratch

Under this agreement, we have become a Mitigator ® distributor whereby we obtain wholesale pricing as a re-seller. We are pleased to announce that we sold approximately $8,000 of this new product later during the fourth quarter of this year.

Government Regulation and Need for Governmental Approval of Principal Products or Services

Because we do not sell a product that makes any particular cure claim, our products are exempt from direct regulation by the federal Food and Drug Administration. We have modified our website to remove any “assumed” claims of any product that we cannot prove.

We do not make any disease-related claims and therefore we are in compliance with FDA and FTC “truth in advertising” laws. (http://www.ftc.gov/bcp/conline/pubs/buspubs/dietsupp.shtm). Also our labels follow FDA guidelines (http://vm.cfsan.fda.gov/~dms/supplmnt.html). Other than state and federal securities laws and possible internet fraud or consumer fraud statutes that various states have enacted, we are not aware of any particular state or federal regulations that affect or impact our current business.

Applicability and Impact of Sales Taxes

With respect to the collection of sales taxes, we have been informed by the Utah State Tax Commission that because we maintain an office in Utah (even though we are a Nevada corporation), we must collect sales taxes from all Utah residents who buy our product on-line. We have obtained a Utah sales tax number for this purpose. Because we are a Nevada corporation, we are also considered to maintain an office in Nevada. This means that we must also pay sales taxes for Nevada residents who buy our product. We have long ago received a Nevada sales tax number for this purpose as well. Both states require filing quarterly sales tax returns. Because we do not maintain an office in any jurisdiction other than Utah and Nevada, we are not, to our knowledge, required to collect sales taxes in or for any other jurisdiction. According to the Utah State Tax Commission, persons who buy our product outside of the State of Utah are supposed to pay a "use tax" to their own respective state taxing authority. Collecting sales or use taxes outside of the States of Utah and Nevada are therefore not our responsibility. Were we to open an office in another state, we would be required to collect sales taxes from purchasers of our product who reside in that state. At present, we only maintain an office in the State of Utah and technically, Nevada. We will thus pay sales taxes in those two states to the extent we have purchasers of our products who reside in either of those two states.

The extent to which the manufacturers of Tonify, X-Mint, Gray-to-Great and Mitigator® maintain a retail or other substantial presence in another state, it is possible that we may be required to charge sales or use taxes to persons who purchase from our website in those particular states. At the present time, we are not aware that such is the case.

Competition, Marketing Data and Information

Tonify, X-Mint, Gray-to-Great and Mitigator®’s manufacturers have other wholesale distributors like us who offer the two products for sale through retailers, dealers and their websites.

As disclosed elsewhere herein, in 2015, we will likely be ceasing to offer Tonify and X-Mint for sale because (1) they have not sold well and (2) inventory for those two products was difficult to maintain during 2014.

Sources and Availability of Raw Materials and Names of Principal Suppliers

Not applicable because we obtain product directly from the manufacturer or a Florida distributor of the manufacturer and, at the same time, we maintain sufficient inventory on hand to satisfy orders. We also ship product directly that is purchased through our website and therefore don’t rely on drop shippers, for example.

Dependence on One or a Few Major Customers

None; not applicable.

Patents, Trademarks, Licenses, Franchises, Concessions, Royalty Agreements or Labor Contracts

Though we have a registered federal trademark or trade name of the two phrases Active Uplift® and All Day Energy Spray®, both of which represent product that we own, we are not marketing these products at the present time. The intellectual property protection that we therefore have on these products is no longer relevant to our current sales efforts and current business activities.

Because we don’t own or license them, we have no intellectual property protection or rights with respect to the 4 products we are retailing on and through our website, namely, Tonify, X-Mint, Gray-to-Great and Mitigator®.

We currently have no franchises, concessions, royalty agreements or labor contracts. As disclosed in earlier Edgar filings, in 2009, we entered into such license agreement with one of our then-directors to market a new product, the formula for which was separately and independently developed by him. Such product is a “super juice ” drink, which we unveiled 3 to 4 years ago and named EpiGaia ™. This is the only license agreement to which we are currently a party and it is essentially moot at the present time. We are not currently marketing this particular product for want of advertising capital and therefore, our plans with respect thereto are “on hold.” This license agreement involves nominal consideration to this former director as a result of his insider status at the time. Because he is no longer on our board and we are not marketing EpiGaia™, these issues are not relevant at the present time. With regard to EpiGaia™, we have included the “ TM ” or trademark designation next to the name EpiGaia ™ in that, on May 7, 2009, we applied, through intellectual property counsel, for a federal trademark and trade name with the U.S. Patent and Trademark office in Washington, D.C. In addition to applying for a federal trademark and trade relative to the name “EpiGaia,” on the same date we also applied for a trade name and trademark for the names “Epigenic Health” and “Epigenic Wellness.” These three (3) applications are identified by Serial Nos.77/.731,844, 77/731,917 and 77/731,888, respectively. We intend to use the TM designation in connection with our use of any of these marks. These three federal trademark applications have been pending for some time. We have no way of knowing, at the present time if our applications will be granted, or, if they or any of them are, when that might occur.

All Day Energy Spray®, on which we have a registered federal trademark, uses a proprietary, natural energy formula called XYTINE™ and on which we also previously filed for a federal trademark or trade name with the U.S. Patent and Trademark Office. See also Item 2 of this Part immediately below titled “PROPERTIES.” Because we are no longer actively marketing these products, we are not aware of the current status of our various trademark and trade name applications and properties.

Research and Development Costs during the Last Two Fiscal Years

During the years ended December 31, 2014 and December 31, 2013, we expended no money towards research and development.

Costs and Effects of Compliance with Environmental Laws

None; not applicable.

Reports to Shareholders

None.

Employees

We currently have no employees and do not anticipate having to hire any other than possibly for part time clerical help or in the event that sales substantially increase or take off. Accordingly, we have no immediate plans to retain employees until such time as our business plans warrant or justify the expense. We may find it necessary to periodically hire part-time clerical help on an as-needed basis though we have no plans to do so at this time.

Facilities

We are now using as our principal place of business the office address of our majority stockholder and two of our directors. That address is 2681 East Parleys Way, Suite 204, Salt Lake City, Utah 84109, phone number 801-322-3401. We have no written agreement with such persons and pay no rent for the use of this facility. Even if we had the capital, because we are a start-up eCommerce retail business, we have no current need or plans to secure separate commercial office space from which to conduct our business. This is also the facility where we store our materials and inventory. This is also at no cost to us at the current time.

Additional Information

ITEM 1A. RISK FACTORS

Not applicable to smaller reporting companies.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None; not applicable.

ITEM 2. PROPERTIES.

We own all right, title and interest in and to our two health and energy products Active UpLift® and All Day Energy Spray®, none of which we are marketing at the present time . Other than as set forth in our license agreement with one of our former directors, we also own all right, title and interest in and to our “super juice ” EpiGaia™, a product that we are also not currently marketing. This interest is through an exclusive licensing agreement mentioned above with a former director. Finally, we own all right title and interest in and to our “Green Tea Diet” drink that we have also been holding off from marketing at the present time.

As set forth in the section above titled Patents, Trademarks, Licenses, Franchises, Concessions, Royalty Agreements or Labor Contracts,” we have a federal trade name and trademark on the phrase Active UpLift® which we obtained in 2008. During our 2009 fiscal year, we received notice from our intellectual property attorneys that our application with the U.S. Patent and Trademark Office for a trade name and trademark on the phrase All Day Energy Spray® had issued and is now registered. This enabled us to put the capital “R” with a circle around it next to the name of both of these products, something that we have routinely done on all of our shipping packages and boxes used in interstate commerce.

We have contemplated filing with the U.S. Patent and Trademark Office for a federal chemical patent on our Active UpLift® formula but have not as yet done so for want of capital. Based on our lack of capital available for such purpose, it is unlikely that we will do so.

We have no proprietary or other interest in the four (4) products we are currently marketing on our website at the present time, namely, Tonify, X-Mint, Gray-to-Great and Mitigator®. We market such products as a distributor only.

Executive Offices

In September 2013, our executive offices were re-located to 2681 East Parleys Way, Suite 204, Salt Lake City, Utah 84109, phone number 801-322-3401. This is also the business office address of our two directors and our principal shareholder. As stated above in the subheading titled “Facilities,” we pay no rent for the use of this address or facility. We do not believe that we will need to maintain any other or additional office space at any time or in the foreseeable future in order to carry out our plan of operations described in this document. This is because our business is primarily “on-line” at the present time, meaning that our current facilities are adequate to meet our needs until something occurs which requires either more or different office space. We do not foresee that in the immediate or foreseeable future.

ITEM 3. LEGAL PROCEEDINGS

None.

ITEM 4. MINE SAFETY DISCLOSURES

None; not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

Market Information

As per information obtained from the OTC Markets Group, Inc. (www.otcmarkets.com), the price and trading activity in our stock for each quarter of fiscal 2014 and 2013 is set forth below.

ISSUE: UPLIFT NUTRITION, INC.

( NV ) COMMON

2014 TRADING INFORMATION REPORT AS REPORTED BY THE FINANCIAL INDUSTRY REGULATORY

AUTHORITY COMPOSITE FEED OR OTHER QUALIFIED INTERDEALER QUOTATION MEDIUM. THE PRIMARY STOCK MARKET LISTING IS NOTED.

ISSUE:

UPLIFT NUTRITION, INC. ( NV )

COMMON

OTC:

CLOSING BID

2014

HIGH

LOW

JAN. 2

THRU

.25

.004

MAR. 31

APR. 1

THRU

.03

.0042

JUNE 30

JULY 1

THRU

.01

.03

SEPT. 30

OCT. 1

THRU

.05

.031

DEC. 31

NOTE: THE INFORMATION IS COMPILED WITH CARE FROM SOURCES BELIEVED TO BE

RELIABLE BUT WE CANNOT GUARANTEE THE ACCURACY NOR WARRANTEE ITS USE FOR ANY

PURPOSE.

NOTE: THE ABOVE QUOTATIONS REPRESENT PRICES BETWEEN DEALERS AND DO NOT

INCLUDE RETAIL MARKUP, MARKDOWN OR COMMISSION. THEY DO NOT REPRESENT ACTUAL

TRANSACTIONS AND HAVE NOT BEEN ADJUSTED FOR STOCK DIVIDENDS OR SPLITS.

NOTE: THE INFORMATION INCLUDED HEREIN IS FOR YOUR INTERNAL USE ONLY, AND MAY

NOT BE REDISTRIBUTED WITHOUT THE PRIOR WRITTEN CONSENT OF OTC MARKETS GROUP.

OTC MARKETS GROUP INC.

	CLOSING BID		CLOSING ASK
2013	HIGH	LOW	HIGH	LOW
JAN. 2 THROUGH MAR 28	.03	.03	.9165	.20
APR. 1 THROUGH JUNE 28	.14	.03	1.01	.20
JULY 1 THROUGH SEPT. 30	.10	.002	.25	.25
OCT. 1 THROUGH DEC. 31	.08	.0022	.25	.25

NOTE: THE INFORMATION ABOVE WAS COMPILED WITH CARE FROM SOURCES BELIEVED TO BE RELIABLE BUT NEITHER PINK SHEETS, LLC, NOR THE OTC BULLETIN BOARD CAN GUARANTEE THE ACCURACY OF OR WARRANTEY OF THIS INFORMATION’S USE FOR ANY PURPOSE.

NOTE : PRICES INDICATED ABOVE HAVE NOT BEEN ADJUSTED FOR STOCK DIVIDENDS OR SPLITS.

NOTE: THE ABOVE BID AND ASK QUOTATIONS REPRESENT PRICES BETWEEN DEALERS AND DO NOT INCLUDE RETAIL MARKUP, MARKDOWN OR COMMISSION. FURTHERMORE, THEY DO NOT REPRESENT ACTUAL TRANSACTIONS.

As of our year end, there were a total of 13,892,597shares issued and outstanding. For more information on who owns our stock and what stock may trade without restriction, see Item 12 of Part III below titled “SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.”

In July 2014, Mr. Deworth Williams, our majority shareholder, sold or conveyed the portion of the Convertible Note that he acquired from Uplift Holdings, LLC (“Uplift Holdings”) in September 2013, to Mr. Edward F. Cowle. At the time that Mr. Williams acquired the Note, it had a face value of approximately $60,000. The face amount of the Note as acquired from Uplift Holdings was thus assigned to Mr. Cowle. Mr. Williams has advanced us additional funds to us since September of 2013, thereby adding to the Note over the last year to the extent of approximately $41,000 as of the end of our fiscal year. See our balance sheet in our audited financial statements filed under Item 8 below. In his partial assignment to Mr. Cowle, Mr. Williams retained that portion of the Note that he added within the last year.

Holders

According to our stock transfer agent, Fidelity Transfer Company, as of the date of this annual report, there are approximately 1,244 holders of record of our common capital stock.

Dividends and Dividend Policy

Description of Securities

Our authorized capital stock consists of 100,000,000 shares of common capital stock, $0.001 par value, of which 13,892,597 shares were issued and outstanding as of our fiscal year-end, December 31, 2014. During February 2014, 200,000 shares were issued to a former director and officer as compensation for services rendered. As also disclosed above, as a result of the November 2011 amendments to our Nevada Articles, our capital stock also consists of an additional 10 million preferred shares which we authorized, having a par value of $0.001 per share, of which none are currently issued or outstanding, the preferences and rights concerning which have not as yet been determined by our Board of Directors. See Exhibit 3.2 hereto referenced in Part IV, Item 15 below.

As of our December 31, 2014, year-end, including the date of this Annual Report, there are NO options, warrants, stock appreciation rights, or other rights of a similar nature outstanding which currently obligate us to issue any additional common stock to anyone. Our common stock is considered a "penny stock" because it meets, or would meet, if and when it trades, one or more of the definitions in Commission Rule 3a51-1 of the Exchange Act. These include but are not limited to the following: (i) the stock trades at a price less than five dollars ($5.00) per share; (ii) it is NOT traded on a "recognized" national exchange; (iii) it is NOT quoted on the FINRA’s automated quotation system (NASDAQ), or even if so, has a price less than five dollars ($5.00) per share; OR (iv) is issued by a company with net tangible assets less than $2,000,000, if in business more than three years continuously, or $5,000,000, if in business less than a continuous three years, or with average revenues of less than $6,000,000 for the past three years. The principal result or effect of being designated a "penny stock" is that securities broker-dealers cannot recommend the stock but must trade in it on an unsolicited basis.

Common Capital Stock

Preemptive Rights, Cumulative Voting and Control

Liquidation Rights

Securities Authorized for Issuance under Equity Compensation Plans

Recent Sales of Unregistered Securities

None during the 2014 calendar year other than on or about February 11, 2014, our Board authorized the issuance of 200,000 “restricted” shares to our then CEO and President, Gary C. Lewis, for services rendered.

Use of Proceeds of Registered Securities

None; not applicable.

Purchases of Equity Securities by Us and Affiliated Purchasers.

We did NOT purchase any of our own securities during the 2014 fiscal year.

Stock Transfer Agent

ITEM 6. SELECTED FINANCIAL DATA

Responding to this item is not required for smaller reporting companies.

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Our principal business plan up to and through the end of the this 2014 fiscal year has been to promote, market and sell Tonify, X-Mint, Gray-to-Great and Mitigator®, four new products, two of which we just started marketing, all as disclosed in Part II, Item 5 below. See our website, www.upliftnutritioninc.com.

As disclosed above, it appears that for 2015, we will cease offering and selling Tonify and X-Mint because (1) sales of those two products has not been what we anticipated and (2) we have difficulty keeping those products in inventory.

Our Websites

Within the last 2 years, we redesigned our principal Uplift website. We also shut down or discontinued our former websites, www.epigaia.com, www.alldayenergyspray.com, and www.upliftenergy.com in favor of just the one website. A couple of years ago, we spent an enormous amount of time and energy revamping and modernizing www.upliftnutritioninc.com and strongly encourage any investor or interested person to visit it.

Inventory

We no longer carry any inventory of Active UpLift® and All Day Energy Spray®. We do maintain limited inventory of Tonify, X-Mint, Gray-to-Great and Mitigator®. Presently, as of the date of this report, we are out of Tonify and X-Mint.

As of December 31, 2014, we had limited Tonify, X-Mint, Gray-to-Great and Mitigator® in inventory. We have not been too concerned about keeping product on hand because it is easy for us to obtain at the present time.

We are NOT Dependent on One Supplier for Our Potential Success

With regard to our products, we are not dependent on any one supplier for our ability to receive and inventory product.

With regard to Tonify and X-Mint, if necessary, we can obtain additional product directly from a distributor in Florida that prior management has known for a long time.

Our Business Plan over the Remainder of the Year

As a result of the recession and people tightening their belts and not spending as much money, we had a difficult time generating sales for Active UpLift® and All Day Energy Spray®. As a result, and as stated above, we decided a couple of years ago to suspend all advertising on those two products and cease selling them. Starting approximately 2 years ago, as disclosed elsewhere herein, we added 2 new products to sell as a broker. In 2014, we added 2 more products. To accommodate these efforts, we have completely updated and expanded our existing website, and have shut down the other two websites leaving www.upliftnutritioninc.com as the only website available for advertising, marketing and sales. As stated elsewhere herein, for want of advertising capital, we no longer offer our Active Uplift® and All Day Energy Spray® products.

We hope that our new marketing efforts related to Gray-to-Great and Mitigator® will be successful but this remains to be seen. Because we are no longer marketing our principal energy drink products and we have embarked on marketing four entirely new products, we do not believe that comparing cost of goods sold for 2014 to 2013 is particularly relevant or meaningful. The increase in revenue primarily occurred due to the Company beginning to sell Mitigator product, during the fourth quarter.

Our marketing expenses for the year ended December 31, 2014 were $174 compared to $1,096 for the year ended December 31, 2013. For the year ended December 31, 2014, we incurred no advertising costs and no costs of connection with product used in demonstrations, free samples, and giveaways in connection with sponsorship of events. We did incur $174 for marketing on our website during the fiscal year.

Consulting and professional fees were $20,434 for the year ended December 31, 2014 compared to $41,339 during the year ended December 31, 2013. No major change was expected in professional fees as we will continue to have audits and reviews of the financial statements and otherwise rely on legal counsel from time to time. These professional fees also include professional Edgarizing costs and fees, which further include the cost of complying with the SEC’s mandated XBRL feature in EDGAR filings.

General and administrative expenses were $1,129 for the year ended December 31, 2014 compared to $7,406 for the year ended December 31, 2013. The decrease is mainly the result of decreased sales and operations and our efforts to further wind down the marketing of our previous energy drinks.

Liquidity and Capital Requirements

As of our fiscal year ended December 31, 2014, we had $10,499 in cash. What we have in our checking or bank account at any given time is insignificant inasmuch as our working capital has historically been provided by our majority shareholder. Though we are accruing 8% interest per annum on the amounts provided by our majority shareholder under the convertible note with him, these advances do not require interest payments at the present time and, unless or until we become profitable, we do not believe that it likely that our agreement with our majority shareholder would be modified to require such. Our majority shareholder’s loans to us are considered or designated by us as "advances" inasmuch as they do not require that we pay interest payments unless demand is made to do so. While we accrue interest or keep track of what it is, at present, we have no way of paying any interest payments to him. As of December 31, 2014, we have accrued $2,463 in interest due and owing to H. Deworth Williams, our majority shareholder. In the event we modify our oral agreement in the future with Mr. Williams so that we are required to pay interest, we do not believe it would have any material impact on us or our liquidity because both we and him would not agree to such a modification unless we were profitable and could afford to make such interest payments.

We hope to be able to satisfy our cash requirements for at least the next 12 to 18 months in that our majority shareholder has committed himself to advancing what funds are necessary for us to satisfy all of our cash requirements and otherwise keep us current in our 1934 Exchange Act reporting obligations for at least the ensuing year or two.

We believe that a year period is consistent with the disclosure in our PLAN OF OPERATION described below in that we believe that within the next year or 2 years, we should be able to successfully carry out our business plan if we can find sufficient advertising capital on acceptable terms. If a determination is made by management within the next year that we will NOT be successful and that our business plan is or will be a failure for reasons which we can only imagine, our majority shareholder may elect not to advance us any more funds. See the section titled "PLAN OF OPERATION" below. Having said this, we are unable to guarantee that at the expiration of two or three years from now, and assuming that our business plan is NOT by then successful, that our majority shareholder will continue to advance us sufficient money to allow us to continue in our reporting obligations. We do not mean to imply, however, that our majority shareholder will NOT continue to advance us funds beyond the next year, particularly if it appears that we will indeed be able to successfully carry out our business plan if we continue beyond the year. If our majority shareholder does not desire to loan or advance us sufficient funds to continue for the simple reason that the prospects of our business plan look bleak, we may be required to look at other business opportunities, the form of which we cannot predict at this time, as to do so would be highly speculative on our part. It is possible, however, that we would consider a private placement of our shares for advertising capital, the form of which we also cannot predict at this time or even taking on an entirely new business.

Our Budget over the Next 12 Months

Due to our lack of working capital necessary to generate a serious and aggressive advertising campaign, we are unable to devise or project an advertising budget for 2015. Assuming that we do not obtain sufficient working capital during the year to embark on an extensive advertising campaign, what capital we have or what advances we will obtain from our majority shareholder will be used, during 2015, to keep us current in our reporting obligations and to pay attorneys, accountants and auditors.

Contingency Planning

Any funding for emergencies is anticipated to be advanced by our majority shareholder.

Off-Balance Sheet Arrangements

None; not applicable.

Effect of Current Economic Conditions

Obviously, current economic conditions are hurting all businesses, not to mention retail outlets and retail sales overall. Most Americans are not spending money today like they have in the past, though they are buying more things on-line. Since much of the effects of the current recession have only become apparent in recent years, we are not in a position at this time to predict the recession’s effects on our overall business plan and plan of operation, not to mention predicting 2015 sales. No retail company that we know of is making any such predictions. We suspect that sales in 2015 will be slower than they might otherwise be, simply because there is some talk of the world’s economy slowing down.

It is also our belief that 3 of 4 products are considered ‘boutique’ products that will sell well as long as the economy does well and the public has extra expendable income. (We do not believe Mitigator® is a boutique product.) Although we are experiencing some sales, the current recession may likely have a negative effect on future sales. We also believe that the particular market for 3 of our 4 products is considered an ‘impulse’ market. This means that sales can be sporadic.

PLAN OF OPERATION

As stated in Items 1 and the beginning of this Item 7 above, our principal business plan has been modified to rebuild our website, www.upliftnutritioninc.com, and enter into a marketing or distributorship agreements to sell at least four (4) new products on-line, two of which we began marketing as recently as 2014. Because of our change in direction, we shut down our two other major websites so we could concentrate all of our marketing and sales efforts on our one principal website.

Shipping of Our New Products

Both Tonify and X-Mint are packaged in DVD-sized containers which are light weight and inexpensive to ship through the US Postal Service or one of the private shipping services. We pass this cost on to the customer. Gray-to-Great and Mitigator® are packaged and shipped in a similar way.

Inventory

As stated in the beginning of Item 1 above, we have phased out the sale of Active UpLift® and All Day Energy Spray®. We do not intend to mix any more of these products. What is on hand and in inventory we will sell on-line until the viability of the product fully expires.

We currently have limted Tonify or X-Mint on hand but we do have $355 worth of Gray-to-Great and Mitigator® on hand.

Our Current On-Line Marketing/Advertising Strategy

As disclosed above, we changed directions in approximately 2 years ago and decided to concentrate our marketing efforts on Tonify and X-Mint. Since then we have added 2 more products. In this regard, we are concentrating our new and current marketing efforts on keeping our current revamped website updated and fully functional. Through these efforts, we have started a marketing effort on various popular and more significant search engines.

In order for our Internet/eCommerce business to succeed, we additionally plan, among those things mentioned above, and on an on-going basis, to:

-- make significant investments in our Internet/eCommerce business, including upgrading our website as it becomes necessary

-- get other food and nutrition websites to link to ours

-- significantly increase online traffic and sales volume in every way we can

-- attract and retain a loyal base of frequent visitors to our website who will give us feedback about our product

-- expand the products and services offered on our website

-- respond to competitive developments and maintain our distinct brand identity

-- form and maintain relationships with strategic partners, particularly retail food stores and outlets

-- provide quality customer service

-- continue to develop and upgrade our services and technologies

We Intend to Pursue Additional Marketing Ideas and Avenues on an On-Going Basis

Marketing ideas that have not as yet been implemented by us for want of capital but which we intend to seriously consider and which are designed to additionally promote us and our website:

1) through reciprocal links with other websites;

(2) through advertising on other health and nutrition websites;

(3) through ads placed in various health and nutrition food magazines to the extent we can afford to place such ads;

(4) through the attendance at health and nutrition tradeshows and expos across the country;

(5) through contacting and then supplying retail food stores across the country, including health food stores, with our product, either on consignment basis or, on a high volume discounted basis for which they will pay us in advance; and

(6) through the giving of product demonstrations in store locations and even malls.

ITEM 7A. QUANTATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

No response to this item is required for smaller reporting companies.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTRY DATA.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and shareholders’

Uplift Nutrition, Inc.

We have audited the accompanying balance sheets of Uplift Nutrition, Inc. (the Company) as of December 31, 2014 and 2013 and the related statements of operations, stockholders’ deficit and cash flows for the years then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion the financial statements referred to above present fairly, in all material respects, the financial position of Uplift Nutrition, Inc. as of December 31, 2014 and 2013, and the results of their operations and cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has recognized minimal revenue and has accumulated losses of $1,605,338 December 31, 2014 which raises substantial doubt about its ability to continue as a going concern. Management’s plans concerning these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ Sadler, Gibb & Associates, LLC

Salt Lake City, UT

April 15, 2015

UPLIFT NUTRITION, INC.
Balance Sheets
ASSETS
			December 31,		December 31,
			2014		2013
CURRENT ASSETS
	Cash		$	10,499	$	2,981
	Accounts Receivable			300		-
	Inventory			355		113
		Total Current Assets		11,154		3,094
PROPERTY AND EQUIPMENT, NET				-		-
OTHER ASSETS
	Patents, net			-		-
		Total Other Assets		-		-
		TOTAL ASSETS	$	11,154	$	3,094
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
	Accounts payable and accrued expenses		$	13,672	$	798
	Accrued interest payable - related party			2,463		3,392
	Due to related parties			41,312		81,811
	Notes Payable			60,000		-
		Total Current Liabilities		117,447		86,001
		TOTAL LIABILITIES		117,447		86,001
STOCKHOLDERS' DEFICIT
	Common stock, $0.001 par value; 100,000,000 shares authorized,
	13,892,597 and 13,692,597 shares issued
	and outstanding, respectively			13,893		13,693
	Additional paid-in capital			1,485,152		1,484,512
	Accumulated deficit			(1,605,338)		(1,581,112)
		Total Stockholders' Deficit		(106,293)		(82,907)
		TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	11,154	$	3,094
The accompanying notes are an integral part of these financial statements.

	UPLIFT NUTRITION, INC.
	Statements of Operations
				For the Years Ended
				December 31,
				2014		2013
NET REVENUES				$	8,806	$	517
OPERATING EXPENSES
		Cost of sales			4,431		7
		Marketing			174		1,096
		Legal and professional fees			20,434		41,339
		Other general and administrative			955		7,406
			Total Operating Expenses		25,994		49,848
LOSS FROM OPERATIONS					(17,188)		(49,331)
OTHER INCOME
		Loss on Impairment			-		(1,711)
		Interest expense - related party			(7,038)		(3,165)
			Total Other Income (Expense)		(7,038)		(4,876)
							.
LOSS BEFORE INCOME TAXES					(24,226)		(54,207)
		Income Taxes			-		-
NET LOSS				$	(24,226)	$	(54,207)
BASIC AND DILUTED LOSS PER SHARE OF
		COMMON STOCK		$	(0.00)	$	(0.00)
WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING					13,869,583		13,692,597
	The accompanying notes are an integral part of these financial statements.

UPLIFT NUTRITION, INC.
Statements of Stockholders' Equity (Deficit)
						Deficit
						Accumulated
				Additional		During the		Total
	Common Stock			Paid-In		Development		Stockholders'
	Shares	Amount		Capital		Stage		Deficit
Balance, December 31, 2012	13,692,597		13,693		1,484,512		(1,526,905)		(28,700)
Net loss for the year ended
December 31, 2013	-		-		-		(54,207)		(54,207)
Balance, December 31, 2013	13,692,597	$	13,693	$	1,484,512	$	(1,581,112)	$	(82,907)
Common stock issued for services
at $0.0042 per common share, Feb 2014	200,000		200		640		-		840
Net loss for the year ended
December 31, 2014	-		-		-		(24,226)		(24,226)
Balance, December 31, 2014	13,892,597	$	13,893	$	1,485,152	$	(1,605,338)	$	(106,293)
The accompanying notes are an integral part of these financial statements.

UPLIFT NUTRITION, INC.
Statements of Cash Flows
			For the Years Ended
			December 31,
			2014		2013
OPERATING ACTIVITIES
	Net loss		$	(24,226)	$	(54,207)
Adjustments to reconcile loss
to cash flows from operating activities
	Depreciation and amortization			-		909
	Recovery of contingency accrual			-		-
	Provision for accounts receivable			-		-
	Stock issued for services			840		-
	Loss on disposal of website			-		-
	Inventory obsolescence			-		-
	Loss in impairment			-		1,711
Changes in operating assets and liabilities
	Inventory			(242)		623
	Accounts receivable			(300)
	Accounts payable			4,907		(17,031)
	Accrued interest – related party			7,038		3,165
		Net Cash Provided by (Used
		in) Operating Activities		(11,983)		(64,830)
INVESTING ACTIVITIES
		Net Cash Used in Investing Activities		-		-
FINANCING ACTIVITIES
	Bank overdraft			-		(300)
	Net advances from shareholders			19,501		68,111
		Net Cash Provided by Financing Activities		19,501		67,811
NET INCREASE IN CASH				7,518		2,981
CASH AT BEGINNING OF PERIOD				2,981		-
CASH AT END OF PERIOD			$	10,499	$	2,981
SUPPLEMENTAL CASH FLOW INFORMATION:
	NON-CASH FINANCING ACTIVITIES:
		Assignment of stockholder note payable	$	60,000	$	-
		Assignment of accrued interest stockholder notes payable	$	5,586		-

UPLIFT NUTRITION, INC.

Notes to the Financial Statements

December 31, 2014 and 2013

Note 1 – Summary of Significant Accounting Policies

Business and Basis of Presentation

Uplift Nutrition, Inc. (“the Company”), a Nevada corporation, is engaged in the business of manufacturing and distributing a nutritional supplement drink mix. The Company’s operations are based in Salt Lake City, Utah. The Company has not generated significant revenue from planned principal operations and is considered a development stage company as defined in FASB ASC 915-10. The Company has, at the present time, not paid any dividends and any dividends that may be paid in the future will depend upon the financial requirements of the Company and other relevant factors.

On June 2, 2006, the Company completed an acquisition with Nu Mineral Health, LLC (“NMH”), a Wyoming limited liability company organized on March 7, 2005 and engaged in the nutritional supplement and nutrition business. The acquisition was effected by the Company issuing 20,000,000 common stock shares to acquire all of the membership interests, accompanying assets and intellectual property of NMH. The merger was accounted for as a recapitalization of NMH with NMH being the accounting survivor and the operating entity. The accompanying financial statements reflect the operations of NMH, for all periods presented and the equity has been restated to reflect the 20,000,000 common stock shares issued in the recapitalization as though the common stock shares had been issued at the inception of NMH.

Cash and Cash Equivalents

The Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents.

Inventory

Inventory is carried at the lower of cost or market, as determined on the first-in, first-out method and is periodically evaluated for obsolescence.

Receivables

Accounts Receivable generally consists of trade receivables arising in the normal course of business. The Company establishes an allowance for doubtful accounts that reflects the Company’s best estimate of probable losses inherent in the accounts receivable balances. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available information. The balance of accounts receivable at December 31, 2014 and 2013 was $300 and $-0- respectively.

Website Costs

The Company has adopted the provisions of FASB ASC 350. Costs incurred in the planning stage of a website are expensed while costs incurred in the development stage are capitalized and amortized over the estimated three-year life of the asset.

UPLIFT NUTRITION, INC.

Notes to the Financial Statements

December 31, 2014 and 2013

Note 1 – Summary of Significant Accounting Policies (Continued)

Intangible Assets

Intangible assets consist of indefinite-life intangible assets which include patents and trademarks. The Company accounts for indefinite-life intangible assets in accordance with FASB ASC 350 and accordingly reviews these assets at least annually for impairment.

Revenue Recognition

The Company recognizes revenue when rights and risk of ownership have passed to the customer, when there is persuasive evidence of an arrangement, product has been shipped or delivered to the customer, the right of return has expired, the price and terms are finalized, and collection of the resulting receivable is reasonably assured. Products are shipped FOB shipping point at which time title passes to the customer.

The Company records revenue net of sales discounts, including coupons, sales incentives, and volume discounts. The Company accounts for product coupon incentives the later of 1) the date at which the related revenue is recognized or 2) the date at which the sales incentive is offered. Coupons are recorded as a discount in revenue. Total discounts for the years ended December 31, 2014 and 2013 were $-0-.

Advertising Cost

Cost incurred in connection with advertising and marketing of the Company’s products are expensed as incurred. Such costs amounted to $174 and $1,096 for the years ended December 31, 2014 and 2013, respectively.

Research and Development Cost

The Company expenses research and development costs for the development of new products as incurred. Such costs for the years ended December 31, 2014 and 2013 were $-0-.

Income Taxes

Prior to June 2, 2006, in lieu of corporate income taxes, the members of NMH were taxed on or allocated their proportionate share of the Company’s taxable income/loss. Therefore, no deferred tax assets or liabilities, income tax payable or current and deferred tax expense or benefit for federal income taxes have been included in the financial statements for the period prior to June 2, 2006. The Company accounts for income taxes in accordance with FASB ASC 740-10 (Prior authoritative literature: Financial Interpretation No. 48, “Accounting for Uncertainty in Income Taxes - An Interpretation of FASB Statement No. 109 (Fin48)).” This statement requires an asset and liability approach for accounting for income taxes.

Loss Per Share

The Company calculates loss per share in accordance with FASB ASC 260. Basic earnings/loss per common share are based on the weighted average number of common shares outstanding during each period. Diluted earnings per common share are based on weighted average number of common shares outstanding during the period plus potentially dilutive common shares from common stock equivalents. The Company has no common stock equivalents for all periods presented.

Fair Value of Financial Instruments

On January 1, 2008, the Company adopted FASB ASC 820-10-50, “Fair Value Measurements.” This guidance defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:

Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Note 1 – Summary of significant Accounting Policies (continued)

Fair Value of Financial Instruments (Continued_

Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement.

The carrying amounts reported in the balance sheets for the cash and cash equivalents, receivables, inventory and current liabilities each qualify as financial instruments and are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest.

Accounting Estimates

Note 2 – Going Concern

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has sustained losses of $1,605,338 from March 7, 2005 (inception) through December 31, 2014 including a loss of $24,226 for the year ended December 31, 2014. The Company has recognized minimal revenue (from March 7, 2005 (inception) through December 31, 2014), which raises substantial doubt about the Company’s ability to continue as a going concern.

In view of the matters described in the preceding paragraph, recoverability of a major portion of the recorded asset amounts shown in the accompanying consolidated balance sheet is dependent upon continued operations of the Company, which in turn is dependent upon the Company's ability to meet its current obligations on a continuing basis, to obtain financing, to acquire additional capital from investors, and to succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence. The Company needs to obtain capital, either long-term debt or equity to continue the implementation of its overall business plan. The Company plans on pursuing the additional capital necessary to continue its overall business plan.

Note 3 – Related Party Transactions

A shareholder of the Company made multiple advances to the Company beginning in the 2008 fiscal year and continuing through 2014. The aggregate total of these advances (net of repayments) was $41,312 and $81,811 at December 31, 2014 and 2013, respectively. The advances are unsecured, accrue interest at an annual rate of eight percent and are payable on demand. As of December 31, 2014 and 2013, the Company has accrued interest due on this note in the amounts of $2,463 and $3,392, respectively.

UPLIFT NUTRITION, INC.

Notes to the Financial Statements

December 31, 2014 and 2013

Note 3 – Related Party Transactions (Continued)

Beginning in October, 2013 a shareholder of the Company made multiple advances to the Company. These advances totaled $101,312 at December 31, 2014. The advances are unsecured, accrue interest at a rate of eight percent per annum, and are payable on demand. As of December 31, 2014 the Company had accrued interest totaling $2,463.

Note 4 – Inventory

Inventory consists of the following:

	December 31, 2014	December 31, 2013
Raw materials and supplies	$ -	$ -
Finished goods	719	113
Total inventory	$ 719	$ 113

Note 5 – Intangible Assets

Intangible assets consist of Trademark application costs totaling $6,593 as of December 31, 2014 and 2013 relating to nutritional supplements sold under the Active Uplift™ label. These intangibles are amortized on a straight line basis over their estimated useful life of 10 years. Accumulated amortization at December 31, 2014 and 2013 was $6,593, and $4,882 respectively. Trademarks were fully impaired during the year, due to the fact that they were not renewed, subsequent to the year end. Patents were $6,593, and accumulated amortization was $6,593 at December 31, 2014.

Note 6 – Income Taxes

At December 31, 2014 the Company had net operating loss carryforwards of approximately $557,302 that may be offset against future taxable income through 2034. No tax benefits have been reported in the financial statements, because the potential tax benefits of the net operating loss carry forwards are offset by a valuation allowance of the same amount.

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carryforwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carryforwards may be limited as to use in the future.

UPLIFT NUTRITION, INC.

Notes to the Financial Statements

December 31, 2014 and 2013

Note 6 – Income Taxes (Continued)

Net deferred tax assets consist of the following components as of December 31, 2014 and 2013:

	2014	2013
Deferred tax assets:
NOL Carryover	$ 545,815	$ 536,651
Common stock issued for services	185,667	185,381
Valuation allowance	(731,481)	(739,432)
Net deferred tax asset	$ -	$ -

	2014	2013
Current Federal Tax	$ -	$ -
Current State Tax	-	-
Change in NOL Benefit	(8,237)	(18,430)
Share-based payments	286	-
Change in valuation allowance	7,951	18,430
	$ -	$ -

At December 31, 2014, the Company had no unrecognized tax benefits that, if recognized, would affect the effective tax rate.

The Company includes interest and penalties arising from the underpayment of income taxes in the consolidated statements of operations in the provision for income taxes. As of December 31, 2014 and 2013, the Company had no accrued interest or penalties related to uncertain tax positions.

The tax years that remain subject to examination by major taxing jurisdictions are those for the years ended December 31, 2014, 2013 and 2012.

Note 7 – Loss Per Share

The following data shows the amounts used in computing loss per share and the effect on income and the weighted average number of shares of potential dilutive common stock for the years ended December 31,

	2014	2013
Net loss (numerator)	$ (24,226)	$ (54,202)
Weighted average shares outstanding (denominator)	13,869,583	13,692,597
Basic and fully diluted net loss per share amount	$ (0.00)	$ (0.00)

For the years ended December 31, 2014 and 2013, the Company had no potentially dilutive common stock equivalents issued.

Note 8 – Stockholders’ Equity

As of December 31, 2014 and 2013, the Company had 13,892,597 shares of $0.001 par value common stock issued and outstanding and an additional 329,501 shares held by the Transfer Agent in reserve to satisfy shares issued through a lost instrument bond, should the holder of an outstanding certificate for stock in the original merger submit his shares in trade for shares in Uplift Nutrition, Inc.

In February 2014 the Company issued 200,000 shares of common stock to an unrelated third party for services rendered. The shares were valued at $0.01 per share, resulting in an aggregate expense of $2,000.

Note 9 – Recent Accounting Pronouncements

The Company has reviewed accounting pronouncements issued during the past two years and have adopted any that are applicable to our company. We have determined that none had a material impact on our financial position, results of operations, or cash flows for the years ended December 31, 2014 and 2013.

In June 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-10, which eliminated certain financial reporting requirements of companies previously identified as “Development Stage Entities” (Topic 915). The amendments in the ASU simplify accounting guidance by removing all incremental financial reporting requirements for development stage entities. The amendments also reduce data maintenance and, for those entities subject to audit, audit costs by eliminating the requirement for development stage entities to present inception-to-date information in the statements of income, cash flows, and shareholder equity. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued (public business entities) or made available for issuance (other entities). Upon adoption, entities will no longer present or disclose any information required by Topic 915. The Company has adopted this standard and will not report inception to date financial information.

Note 10 – Subsequent Events

The Company has evaluated events occurring after the date of our accompanying balance sheets through the date the financial statement were filed. The Company has not identified any material subsequent events requiring adjustment to our financial statements.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of December 31, 2014, these disclosure controls and procedures were ineffective to ensure that all information required to be disclosed by us in the reports that we file or submit under the Exchange Act is: (i) recorded, processed, summarized and reported, within the time periods specified in the Commission’s rule and forms; and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Management’s Annual Report on Internal Control over Financial Reporting

Our management conducted an evaluation of the effectiveness of our internal control over financial reporting. Based on our evaluation, management concluded that our internal control over financial reporting was ineffective for both of our fiscal years ended December 31, 2014, in which there was no material weakness. A material weakness in internal control over financial reporting is defined by the Public Company Accounting Oversight Board’s Audit Standard No. 5 as a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of our financial reporting.

ITEM 9B. OTHER INFORMATION

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Executive Officers and Directors

As disclosed in our last quarterly filing on Form 10-Q, on September 15, 2014, Gary C. Lewis resigned from our Board of Directors and as President, CEO and CFO to pursue full time employment with The Home Depot. We greatly appreciate all of Mr. Lewis’s dedicated work for and in behalf of the Company over the past several years. Director Geoff Williams took Mr. Lewis’s place or position as our Chairman of the Board, President, CEO and chief financial officer (CFO) effective September 16, 2014. Our current directors, officers and “control persons” are as follows:

Name	Age	Position
Geoff Williams	44	Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer
Rachel Winn	44	Director

GEOFF WILLIAMS, Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, and Secretary/Treasurer. Since 1994, Mr. Williams has been a representative of and partner in Williams Investment Company, a Salt Lake City, Utah, financial consulting and corporate services firm involved in facilitating and structuring mergers, acquisitions, business consolidations and financings. Geoff has been instrumental in negotiating well over thirty of these transactions, most of which have resulted in private companies going public, and subsequently being traded on various public exchanges. In addition, Geoff has often arranged financings for these companies, as well as others. For numerous years he sat on the board, and was one of three founding principals of U.S. Rare Earths, Inc. (OTC BB: UREE ), a publicly-held mineral exploration company. He has been on the board of directors of several companies, most recently Protect Pharmaceutical Corporation (OTC BB: PRTT ). Geoff also oversees the real estate division of Williams Investment Company, which currently has undertakings in several locations across the Intermountain West, as well as Hawaii, California, and Baja California, Mexico. Mr. Williams attended the University of Utah, California Institute of the Arts, and La Sorbonne (Paris, France).

Mr. Williams has also served as a director, President, CEO, principal financial officer and principal accounting officer of Eastgate Acquisitions Corp., a reporting company, since its inception in September 1999. He resigned as its President and CEO on May 22, 2012. He is also currently a director, President and CEO of Westgate Acquisitions Corp. and, until he resigned in February 2010, he was a director, President and CEO of Greyhound Commissary, Inc., now known as Tanke Biosciences Corp. He is the son of Uplift Nutrition’s principal and majority shareholder, H. Deworth Williams.

RACHEL WINN , Director. Ms. Winn is currently employed as Assistant Office Manager at Williams Investment Company, in Salt Lake City, Utah, a financial consulting and corporate services firm involved in facilitating and structuring mergers, acquisitions, business consolidations and financings. Outside of her office duties, Ms. Winn also serves as a member and principal shareholder of Fortune Viniculture, L.L.C., a limited liability company which holds interests in vineyard properties located near Ensenada, Mexico. Additionally, she is the personal Executive Assistant to the Director of Operations of Elite Engineering Solutions, L.L.C., a company offering government compliance services, manufacturing and testing.

Family Relationships

Geoff Williams and Rachel Winn, are married. Geoff Williams is also the son of our principal and majority shareholder, H. Deworth Williams.

Other Matters Relating to Our Management

None of our officers or directors devotes his or her full time to the management of the Company. Since all three individuals have full-time jobs, each estimates that they will devote between 1% and 10% of their time to the Company and its affairs. We believe that this may be as many as 5 hours per week on the part of each officer and director. Obviously, much of this will depend on how the Company’s future business and sales unfold. Ms. Winn’s efforts will concentrate on product development. Mr. Williams’ efforts will concentrate on the business end of the Company such as marketing and sales.

None of our officers and directors, not to mention our majority shareholder, has been involved, directly or indirectly, in any bankruptcy or insolvency proceeding of any kind. None is currently involved in any litigation nor has any been involved in any litigation that would have a bearing on any such person's fitness or other ability to act and serve as a director or officer of the Company.

Board Meetings and Committees

During the 2014 fiscal year and through the present, nearly all of our Board Meetings were conducted or held in person at our offices where our directors and our majority shareholder work. Some of these Board Meetings have been formalized into written consent minutes and some have simply been advisory in nature, followed up by written consent or other minutes.

Compliance with Section 16(a) of the Securities Exchange Act of 1934

Director and Officer Liability Limitations

ITEM 11. EXECUTIVE COMPENSATION

During 2014 and 2013, none of our current officers or directors received any salary or any stock as bonuses, for compensation, or for any other reason. The only officer or director who received compensation of any type or kind over the last two years was our former officer and director, Gary C. Lewis, an individual who had been with us since 2007. In February 2014, he was awarded 200,000 “restricted” shares as compensation for services rendered. Mr. Lewis left us on September 15, 2014 to pursue other opportunities. See the Summary Compensation Table immediately below:

SUMMARY COMPENSATION TABLE

Name and Principal Position (a)	Year (b)	Salary ($) (c)	Bonus ($) (d)	Stock Awards ($) (e)	Option Awards ($) (f)	Non-Equity Incentive Plan Compensation ($) (g)	Nonqualified Deferred Compensation ($) (h)	All Other Compensation ($) (i)	Total Earnings ($) (j)
Jessica Stone Rampton, Sec/Treas., CSO and Director thru July 16, 2014	12/31/2014 12/31/2013	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Edward H. Hall, Former Chairman of the Board thru Sept. 6, 2013	12/31/2013	0	0	0	0	0	0	0	0
Gary C. Lewis President, CEO, CFO and Chairman of the Board thru Sept. 15, 2014	12/31/2014 12/31/2013	0	0	$840 0	0 0	0 0	0 0	0 0	0 0
Bruce Miller, Vice President and Director thru Sept. 6, 2013	12/31/2013	0	0	0	0	0	0	0	0
Geoff Williams, Director after Sept. 6, 2013 and President, CEO, CFO and Chairman of our Board of Directors after resignation of Gary C. Lewis on September 15, 2014	12/31/2014 12/31/2013	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Rachel Winn, Director after Sept. 6, 2013	12/31/2014 12/31/2013	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0

We have NOT adopted a bonus, stock option, profit sharing, or deferred compensation plan of any sort for the benefit of our employees, officers or directors. This, however, does not mean that we will not do so in the future, given that we are authorized by our Amended Articles to do so without further shareholder approval. See Exhibit 3.2 hereto referenced in Part IV, Item 15 below. Further, we have not entered into an employment agreement of any kind with any of our directors or officers or any other persons and no such agreements are anticipated in the immediate or near future.

Absence of Management Employment and Other Compensation Agreements

We do not at this time pay any of our officers any salary. We do not provide any other benefits to our officers. We do not have any written agreements with any of our officers and directors.

Each of our officers and directors may engage in other businesses, either individually or through partnerships, limited liability companies, or corporations in which they have an interest, hold an office or serve on boards of directors. All officers and directors have, or will have, other business interests to which they devote their time. Because each of our officers have other full-time employment, each will probably devote no more than between 1% and 10% of their time to us and our affairs. We believe that this will amount to approximately 5 to 10 hours per week depending upon what is going on with our business and affairs.

Other Key Advisors and Consultants

Remuneration and Compensation of Directors

There are no standard arrangements pursuant to which our directors are compensated for any services provided as director, including services for committee participation or for special assignments.

Our Chairman of the Board, President, CEO, and CFO, Gary C. Lewis, received 200,000 “restricted” shares in February 2014 for services rendered as of such date. These are the only shares we issued during 2014. Nor have any additional shares been issued between December 31, 2014 and as of the date of this report.

Absence of Key Man Life Insurance

Indemnification of Our Officers and Directors

Outstanding Equity Awards at Fiscal Year-End

None during fiscal 2014. However, as stated above, on February 11, 2014, 1 of our 4 directors at the time, namely, Mr. Lewis, was awarded a total of 200,000 “restricted” shares for services rendered as of the date of the award. This increased our issued and outstanding shares by such amount during 2014.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Name of Beneficial Owner	Number of Shares of Common Stock Beneficially* Owned	Percent of Ownership of Common Stock Outstanding
Geoff Williams (1) 2681 East Parleys Way, Suite 204 Salt Lake City, Utah 84109	441,600	3.1%
Rachel Winn (2) 2681 East Parleys Way, Suite 204 Salt Lake City, Utah 84109	- 0 -	0%
H. Deworth Williams (3) 2681 East Parleys Way, Suite 204 Salt Lake City, Utah 84109	10,401,550	74.8%
Directors, officer and 5% or more holders as a group (5 persons only)	10,843,150	78%

------------------------------

* Beneficial ownership is determined in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC) and generally includes voting or investment power with respect to securities. Shares of common stock issuable upon the exercise of options or warrants currently exercisable, or exercisable or convertible within 60 days, are also deemed outstanding for computing the percentage ownership of the person holding such options or warrants but are not deemed outstanding for computing the percentage ownership of any other person. Nonetheless, the Company has no outstanding stock options, warrants or compensation plans of any kind.

(1) GEOFF WILLIAMS, a Director, acquired his shares on or about September 6, 2013, in the change of control transaction reported on Edgar on Form 8-K, at which time he also became a Director. Effective September 15, 2014, Mr. Williams took over for Mr. Gary C. Lewis who resigned from his position as our Chairman of the Board and as our President, CEO, CFO. Mr. Lewis resigned to pursue employment with The Home Depot.

(2) RACHEL WINN, a Director, became a Director of Uplift on or about September 6, 2013, pursuant to the change of control transaction reported on Edgar on Form 8-K.

(3) H. DEWORTH WILLIAMS, the father of Geoff Williams, acquired his shares, namely, voting control of the Issuer, on or about September 6, 2013, in a change of control transaction reported on EDGAR on Form 8-K.

None of the foregoing persons hold any shares of the Company pursuant to any voting trust or similar agreement.

As of the date of this report, there are no arrangements or agreements with anyone which may result in a change of control of the Company.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

During the fiscal year, no transactions occurred during the fiscal year between us and any director or officer or any member of any such person’s immediate family.

As disclosed elsewhere above, our majority stockholder, H. Deworth Williams, has agreed to fund us as necessary to keep us current in our SEC reporting obligations. However, such commitment does not include providing the funding as necessary to implement advertising campaigns and therefore, our Board of Directors has resolved to look at additional funding opportunities. While we accrue interest on Mr. Williams’ advances at 8% per annum, all as represented by a certain Convertible Note, these advances do NOT presently require that we pay interest payments. At the same time, other than the Convertible Note itself, there is no written agreement in this regard between us and Mr. Williams. If we ever became profitable, we would consider paying Mr. Williams interest on its advances but only if doing so would have no material impact on our capital resources and liquidity. Having said this, if we became profitable, we plan on spending any earnings on advertising campaigns as opposed to spending such money on the payment of interest. Because of Mr. Williams’ substantial stock ownership interest in us, spending earnings on advertising as opposed to using earnings to pay him interest would likely be in his best interest as well.

Like any other corporate officer or director, each director and officer is subject to the doctrine of usurpation of corporate opportunities only insofar as it applies to business transactions in which we have indicated an interest, either through our proposed business plan or by way of an express statement of interest contained in our minutes. If any director or officer is presented in the future with a business opportunity that may conflict with business interests identified by us, such an opportunity must be promptly disclosed to the Board of Directors and otherwise made known to us. In the event that the Board rejects an opportunity so presented, and only in that event, can one of our officers or directors avail him or herself of such opportunity. In spite of these eventualities, every effort will be made to resolve any conflicts that may arise in favor of us and our stockholders. There can be no assurance, however, that these efforts will be successful. As a Nevada corporation, we are obligated, among other things, to comply with the provisions of Nevada law, NRS 78.140 titled "Restrictions on transactions involving interested directors or officers; compensation of directors." We are not aware of any such conflicts of interest at this time and to be more specific, we are not aware of any opportunity whatsoever that we would reject and that an officer or director or even our majority stockholder would likely engage in or take advantage of.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

Fee Category	2014		2013
Audit Fees	$	12,000	$	17,058
Audit-related Fees		0		0
Tax Fees		0		0
All Other Fees		0		0
Total Fees	$	12,000	$	17,058

Audit fees for the years ended December 31, 2014 and 2013 were for professional services rendered for the audits of our financial statements, quarterly review of the financial statements included in the Quarterly Reports on Form 10-Q, consents and other assistance required to complete the year- end audit of our financial statements.

Audit-Related Fees as of the years ended December 31, 2014 and 2013 were for the assurance and related services reasonably related to the performance of the audit or review of financial statements and not reported under the caption Audit Fees.

Tax Fees as of the years ended December 31, 2014 and 2013 were for professional services related to tax compliance, tax authority audit support and tax planning.

There were no fees that were classified as All Other Fees as of the years ended December 31, 2014 and 2013.

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.

The following Exhibits are filed as a part of this Annual Report on Form 10-K:

Exhibit Number	Description
31	Sarbanes-Oxley Section 302 Certifications
32	Sarbanes-Oxley Section 906 Certification

* Summaries of all exhibits contained within this Annual Report are modified in their entirety by reference to the foregoing Exhibits.

The following Exhibits are incorporated by reference as a part of this Annual Report on Form 10-K:

3.1 Articles of Incorporation, which were filed as an exhibit to our November 2, 2007, Form 10-SB registration statement

3.2 Amendments to our Articles of Incorporation filed with and stamped by the State of Nevada on November 21, 2011 and the corollary Nevada Certificate of Amendment, copies of which were filed with our 2012 Annual Report on Form 10-K

3.3 Bylaws, which were filed as an exhibit to our November 2, 2007, Form 10-SB registration statement

SIGNATURES

In accordance with the provisions of the Securities and Exchange Act of 1934 and the rules and regulations promulgated thereunder, UPLIFT NUTRITION, INC., has duly caused this Annual Report on Form 10-K for its fiscal year ended December 31, 2014, to be signed on its behalf by the undersigned, thereunto duly authorized.

UPLIFT NUTRITION, INC., Issuer

Date:	April 15, 2015	By:	/s/ Geoff Williams
			Geoff Williams
			President, Chief Executive Officer and CFO (Principal Accounting and Financial Officer

Date:	April 15, 2015	By:	/s/ Geoff Williams
			Geoff Williams
			Chairman of the Board

Filing Compare · Uplift Nutrition, Inc.